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ABSTRACT 
Tunicates have proven to be a rich source of 
structurally-diverse metabolites covering a broad spectrum 
of biological activities. Initial testing of the methanolic 
extract from three Pacific didemnid tunicates indicated the 
presence of cytotoxic metabolites. The active compounds 
were isolated by various chromatographic procedures and 
their structures elucidated by spectroscopic techniques (UV, 
MS, IR, NMR). In addition, derivatization, chemical 
conversion and total synthesis were performed to secure the 
assigned structures. 
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BIOLOGY OF TUNICATES 
The phylum Chordata represents a diverse group of 
vertebrate animals. However, within the chordate hierarchy 
is a subphylum, Tunicata, (= Urochordata), whose members do 
not possess vertebrae. Their eggs develop tiny, free 
swimming "tadpole larvae ll possessing a notochord which acts 
as a dorsal supporting structure and a dorsal hollow nerve 
cord, both of which are missing in some adult forms, and 
pharyngeal slits. These three characteristics allow 
placement of tunicates into the chordate family, (Table 1).1 
Many scientists feel that tunicates represent the anatomical 
organization from which the earliest vertebrates originated 
at the beginning of the Paleozoic era. 
Due to their evolutionary position as probable 
vertebrate ancestors the biology of tunicates has been 
thoroughly investigated. Most tunicates are soft-bodied 
organisms. Therefore, there are few known fossils that have 
been uncovered. They are exclusively marine and are found 
allover the world from coastal tide pools to a hundred 
miles out to sea on the continental shelves. 
Most tunicates, (2000 species), are sessile animals 
remaining permanently attached to coral reefs, seaweeds or 
shells. About 100 species have become secondarily modified 
Table 1 
Taxonomy of Tunicates 
Phyl urn ............ Chordata 
Subphylum ......... Tunicata 
Class ............. Thaliacea (scalps) 
Larvacea (appendicularians) 
Ascidiacea (sea squirts) 
for a pelagic life; however, these modifications enabling 
their oceanic existence have drastically altered their 
structural features from the normal. Both sessile and 
pelagic tunicates exist in two different forms - simple and 
compound (colonial). The simple tunicates are solitary 
individuals of relatively uniform proportion. The general 
shape of colonial tunicates is much less uniform. They can 
exist as massive colonies of brilliantly colored 
individuals, sometimes connected by a common creeping 
stolon, or as thin encrusting species on marine plants and 
shells. 
The subphylum Tunicata is divided into three classes, 
Ascidiacea, Thaliacea, and Larvacea. Thaliacea, (i.e., 
Salpa, Doliolum, Pyrosoma, Cyclosalpa), are pelagic 
tunicates living in warm waters (Figure I). They have 
circular bands of muscles enabling the animal to shoot 
2 
3 
through the water by jet propulsion. The mouth and 
atriopore are at opposite ends of the body. The tunic is 
thin and, like the rest of the body, transparent. Salps 
have the ability to swim forward or backwards but their 
outstanding characteristic is the powerful luminescent light 
that shines when the animal is stimulated. Scientists 
believe that the flashes of light protect the salps against 
enemies. This is based on laboratory observations that show 
dying colonies of Pyrosoma that do not light up being eaten 
by fish whereas those that light up when seized are 
subsequently dropped. Larvacea, (i.e., Appendicularia, 
Oikopleura), are small pelagic tunicates that retain some 
larval or immature characteristics in adulthood (Figure 2). 
Hence the name Larvacea given to this class. They represent 
a very common and important component of the planktonic 
community. Interestingly, instead of a tunic, each 
individual builds a house by secretion from a special part 
of the skin, the "oikoplastic epithelium." Tail movements 
cause a current of water to pass through an elaborate 
filtering apparatus in the house. Nanoplankton are trapped 
by filter pipes and surface in front of the mouth. At 
frequent intervals the tail movements stop and the food 
particles are sucked back into the mouth. After a few hours 
the filtering system becomes clogged. The house is then 
abandoned and a new one secreted. An important modification 
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Figure 1. Structure of Thaliacea 15 
Reprinted by permission 
Figure 2. Structure of Larvacea 15 
Reprinted by permission 
4 
existence is the development of the tail into a highly 
specialized organ that supplies locomotion, nutrition and 
aids in the building of the house. (The larval tail of 
Thaliacea and Ascidiacea species is ultimately absorbed.) 
5 
In contrast to Thaliacea, (salps), and Larvacea, 
(appendicularians), which exist in a pelagic environment, 
members of the class Ascidiacea, (i .e., Ciona, Ascidia, 
Eudistoma, Didemnum, Lissoclinum), are usually benthic in 
their adult stage. For this reason Ascidiacea, (ascidians 
or sea squirts), are collected much more easily and 
therefore have been studied in much greater detail. The 
remainder of this thesis will concentrate on members of this 
class. 
Ascidians are mainly sessile organisms that can be 
found living on the sea floor or attached to marine plants 
and shells. They occur as solitary organisms or as colonies 
of individuals. The former state is possibly the primitive 
condition for the group. These sac-like creatures, (Figure 
3), obtain their food by ciliary action. The entire body is 
covered by a tough barrel-shaped covering or tunic in which 
there are only two siphon openings, an incurrent (oral) 
opening and a dorsal excurrent (atrial) opening. The tunic 
lends protection and support to the animal. It is a living 
tissue supplied by blood vessels and composed largely of 
fibers of a carbohydrate tunicin, (closely related to 
cellulose), embedded in a ground substance of acid 
6 
mucopolysaccharide with some protein. The tunic is lined by 
a mantle covered by a single-layered epidermis. The mantle 
contains longitudinal muscle fibers which draw the animal 
together and in the process expel a jet of water from the 
animal, hence the name sea squirt. Most of the body is 
comprised of an immense pharynx beginning below the mouth 
and forming a sac reaching nearly to the base. The pharynx 
serves as a food-collecting apparatus. Its walls are 
pierced by rows of gill slits whose muscular cilia set 
up a food current entering at the mouth and exiting from the 
atrium. An endostyle runs longitudinally along the outside 
of the pharynx (Figure 4). It has three rows of secretory 
cells separated by rows of cilia cells with a single median 
set of cells with very long cilia. The inner rows of 
secretory cells secrete protein, the outer row secretes 
iodinated tyrosine. The iodine is supplied by iodine-uptake 
cells (Figure 4)2. The resulting substance, iodinated 
protein, is spread over the inside of the pharynx. Food 
particles are caught in this layer and the entire curtain is 
digested. 
Autoradiographs made from tunicates that had been 
provided with isotopes of iodine indicated that the major 
compounds formed were 3-iodotyrosine (1) and 3,5-
d;iodotyrosine (£).3 These compounds show a close 
structural resemblance to thyroxin (1) and triiodothyronine 








Figure 3. Structure of Ascidiacea 15 
Reprinted by permission 
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Figure 4. The structure of an endostyle 15 

















thyroid gland. This new information sparked interest in the 
search for a prototype of the thyroid gland. Salvatore 
confirmed the presence of the necessary machinery for the 
biosynthesis of thyroxin in certain tunicate species. His 
elegant experiments suggested that the major site for the 
synthetic process was the tunic and not the endosytle which 
had been assumed to be a homologous organ of the thyroid 
gland. 4 In a similar set of experiments Suzuki also 
demonstrated that 90% of the incorporated 131 1 was found in 
the tunic proteins. 3 However, Suzuki felt that the tunic 
was, from an embryological or evolutionary viewpoint, a very 
unlikely prototype for the thyroid gland and thought it more 
reasonable to study those organs of the tunicate that could 
serve as the functional prototype. His previous studies had 
revealed a higher incorporation of 131 1 into the iodo-amino 
acids of branchial sac (pharynx) proteins rather than into 
those of the endostyle proteins or other tissue proteins. S 
The branchial elements in vertebrates are embryologically 
related to the thyroid. 6 Therefore, Suzuki proposed that 
the branchial sac of tunicates functionally resembled the 
thyroid gland of vertebrates based on the presence of large 
molecules with iodo-amino acid residues in their peptides. 
(These molecules also appeared to have a subunit structure 
similar to thyroglobulin). He also hypothesized that part 
of the biosynthetic machinery for producing hormones had 
already appeared in the branchial sac of tunicates. 
10 
Returning now to the morphology of tunicates, the 
oesophagus leads to a large stomach with a folded wall 
containing gland cells that produce mucus and digestive 
enzymes. The enzymes present include amylase, invertase, 
lipase, and a weak protease. The organ is therefore unlike 
the stomach of a vertebrate- it contains no cellulase. A 
short intestine extends from the stomach and leads upwards 
to open by a rectum near the atrium. The intestine is the 
absorptive region of the gut and is lined by mucus-secreting 
and absorptive cells. The curtain of iodinated protein is 
formed into a food cord by the cilia of the oesophagus 
before being "softened" by the enzymes in the stomach. 
Digestion is extracellular and there is no evidence of 
uptake of solid particles. 
The heart, lying below the pharynx, is a sac surrounded 
by a pericardium. Blood circulation is similar to that in 
vertebrates but there are no capillaries and no valves. The 
blood circulates in a closed system of spaces pumped by 
peristaltic contractions passing from one end of the heart 
to the other, first in one direction for 2-3 minutes and 
then the other. The periodic reversal may be connected with 
the need to supply blood to the tunic as well as to the 
brachial sac and viscera. The blood system distributes 
digested food materials, oxygen and a store of inorganic 
ions. The blood plasma is colorless but contains several 
types of compounds. The blood cells contain pigments which 
1 1 
complex trace metals such as vanadium, iron, titanium, 
tantalum or niobium. 7- 9 Kustin demonstrated the extraction 
of vanadium from sea water 10 and Dingley showed that this 
occurs via a specific anion transport system ll housed in the 
branchial epithelium. Vanadium, whose concentration may be 
a million times greater in the ascidian than in the sea, ;s 
then transported to other parts of the tunicate via the 
blood cells. The heavy metal chromogens of these morula 
cells act as powerful reducing agents being held in their 
reduced state by sulfuric acid. They break up in the tunic 
and assist in the conversion of simple carbohydrates to 
polysaccharides. 
The blood is isotonic with sea water but has little 
sulfate. Since tunicates are exclusively marine organisms it 
is not surprising that they have no power in regulating 
their osmotic pressure. As a result they are unable to 
colonize brackish waters or those of low salinity. An 
explanation for this uncommon vertebrate trait is the need 
to expose a large surface area to the water. Also, 
tunicates do not possess tubular excretory organs that could 
maintain an osmotic gradient. As a result, 95% of the 
nitrogenous waste products are excreted as ammonia. 
Ascidians possess a central nervous system consisting 
of a round solid ganglion lying above the front end of the 
pharynx. The ganglion is unlike the nerve cord of 
vertebrates in that it has a surrounding layer of cells and 
a central mass of neuropi 1. From the gangl ion, nerves 
proceed to the siphons, mantle, muscle, and viscera. 
12 
Movement consists mainly of contraction and closure of 
the apertures. The amount of closure is proportional to the 
strength of the stimulus. Interestingly, when the interior 
of one of the siphons is aggravated the other siphon closes 
first, followed by the one stimulated and finally 
contraction of the body occurs, causing a jet of water to be 
expelled out the stimulated siphon. 
The surface of the body is sensitive to changes in 
light intensity. Local or total contractions are observable 
with the highest sensitivity being in the region of the 
ganglion. 
The neuromuscular system serves as a reflex apparatus 
for producing protective movements in response to certain 
stimuli. Although most ascidians are sessile organisms, the 
nervous system is not activated merely by external stimuli. 
Some experiments suggest that "rhythmical" activities are 
initiated from within, one example being a hunger 
contraction in the absence of food. The food-collecting 
operation is regulated by cilia found along the pharyngeal 
wall. In the absence of food a "hunger contraction" occurs 
causing more water to pass through the machinery than by the 
ciliary current alone. 
The neural gland is a sac lying beneath the ganglion 
and opening by a ciliated funnel on the roof of the pharynx. 
It originates from the ectoderm of the larval nervous 
system. It has been compared with the infundibulum and 
hypophysis of vertebrates. It also displays similarities 
with the pituitary in that it controls the release of 
gametes. The position of the gland suggests a connection 
with the feeding mechanism and there is a daily cycle of 
secretion, the product of which may be mixed with the food 
cord. It is possible that this pharyngal mucus-secreting 
organ stimulated by the environment has evolved into a 
glycoprotein-secreting endocrine gland controlled by 
substances reaching it in the b1ood. 12 
13 
Tunicates are hermaphrodites. The ovaries and testis 
are sacs lying close to the intestine that open by ducts 
near the atrium. Solitary ascidians pass their eggs 
directly into the sea water where they develop into fish-
like larvae. In colonial ascidians the eggs are fertilized 
at the upper end of the oviducts and develop in the atrial 
cavity to the tadpole stage. The tadpole larva (Figure 5, 
left) is distinctive, possessing an eyespot, four rows of 
gill slits and a tail containing a fine dorsal nerve cord 
and a thicker rod or notochord. The mouth of the larvae 
remains undeveloped. Therefore the ascidian never feeds 
during development. The larvae swims a few minutes to an 
hour, then becomes attached to a suitable benthic surface at 
the front end. The tail is rapidly reabsorbed, a large 
pharynx develops, and the two siphons break through. The 
14 
entir development process takes one to two days. The whole 
development process is so strikingly like that of chordates 
that it establishes the affinities of the tunicates far more 
clearly than the vague indications of a chordate plan of 
organization seen in the adult. 
Tunicates also undergo vegetative budding of the parent 
individual (Figure 5, right). In certain species this 
second form of reproduction may occur coincidentally with 
sexual reproduction. A long branching stolon appears from 
under each zooid. At irregular intervals a portion of the 
stolon thickens and buds form. Each bud develops into a 
parent without passing through the larval stage. In some 
species the zooids form a branching colony interconnected by 
the stolon through which the communal blood system flows. 
In others, the zooids separate from the parent and become 
solitary individuals. Many simple ascidian species are 
incapable of vegetative budding. 
The life span of a typical ascidian species is 
approximately one year. However, this is sufficient to 
allow distribution and continuation of the species. 13 - 16 
15 
Figure 5 R . eproduct' . R • 10n ln tunicates 14 
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SYMBIOSIS IN DIDEMNID TUNICATES 
A phenomenon that has intrigued scientists for many 
years is the symbiotic association between certain marine 
ascidians and unicellular algae. The algae are found living 
on the surface or within the cloacal cavities of certain 
didemnid ascidians (i .e., Didemnum voeltzkowi, Lissocl inurn 
patella, Trididemnum cyclops). This association represents 
the highest life form that uses symbionts to contribute to 
its nutrition. The literature describing the taxonomy of 
the symbiont has demonstrated a general confusion concerning 
its phylogenetic position. The microscopic algae, once 
thought to be a zooxanthellae 17 and later defined as 
zoochlorellae 18 synthesizes chlorophylls a & b (i.e., 
eukaryotes) but no phycobilin pigments and has a prokaryotic 
cellular organization. This necessitated that the algae be 
placed in a new plant division, the Prochlorophyta, 19 in the 
new genus Prochloron. 20 The literature investigating the 
nutritive role of the symbiont i s equally rich i n 
conflicting opinions. In 1935 Smith suggested that, even 
though the augmented concentrations of C02 produced by the 
tunicates were peculiarly suited to the algal physiology 
which in return provided photosynthetically-evolved oxygen, 
the algae did not contribute significantly to the nutrition 
of the host. 17 Twenty years later, however, the elegant 
17 
work of Sargent and Austin21 and of Odum and Odum22 
suggested that the abundant presence in coral reef 
communities of photosynthetic algae was crucial to growth 
and maintenance of the entire reef biotope. Recently, 
Akazawa 23 and Pardy and Lewin,24 using 14C02, corroborated 
the nutritive role of the algae by demonstrating the 
photosynthetic capacity of the algal symbiont to supply the 
host with 02 and low molecular weight molecules. 
In the past eight years tunicates have proven to be a 
rich source of biologically active compounds. Several 
nitrogen containing compounds have been isolated from 
didemnid species harboring algal symbionts. The ability of 
certain algal species to fix nitrogen 25 prompted scientists 
to speculate a biosynthetic role for the unicellular algae. 
The contribution from the tunicate and its host in the 
biosynthesis of these compounds remains an intriguing 
question. Complex molecules have been isolated from several 
ascidian species devoid of algal symbionts (i.e., Ascidia 
nigra)26 suggesting that they possess the necessary 
biosynthetic machinery. Evidence also exists suggesting 
that some sponge metabolites are derived from their 
symbiotic microorganisms. 27 
The biosynthetic origin of these compounds will remain 
a mystery until the host and the symbiont are cultured 
separately and the compounds produced by each organism are 
isolated. Bancroft successfully cultured colonies of 
18 
Botryllus and Botrylloides, both encrusting ascidians in 
their natural habitat, easily obtaining vigorous growth and 
sexual reproduction. 28 Culturing the algal symbionts is 
dependent on the ability to free them from their host. 
Lewin demonstrated the ability to free Prochloron from the 
didemnids. 29 Unfortunately, all attempts at culturing 
Prochloron failed until Patterson and Withers determined 
that cell division occurs under acidic conditions (pH 5.5) 
in the presence of tryptophan. 3D The culturing of the 
aposymbiont 31 involves culturing the symbiont-containing 
tunicate in the dark thereby causing the tunicate to expel 
the symbiont. This has yet to be demonstrated successfully. 
THE CHEMISTRY OF TUNICATES 
Rinehart 32 and Weinheimer 33 demonstrated that crude 
extracts from several tunicate species possessed significant 
biological activity. This prompted several research groups 
working independently to isolate and identify the active 
compounds. The potent metabolites covered a broad spectrum 
of activities (i.e., cytotoxic, antibiotic, antiviral, 
antimicrobial). In some cases the novelty of these compounds 
was more interesting than their biological activity. Many 
of these compounds have become target molecules for synthetic 
research groups. Biosynthetically, the metabolites can be 
divided into two major groups: those derived from acetyl CoA 
and those derived from amino acids. The latter group 
includes the majority of the metabolites, a fact that is not 
surprising since tunicates have demonstrated the ability to 
absorb amino acids from sea water. IS 
An example of amino acid derived metabolites are 
polyandrocarpidine I (~) and II (~), derived from a red 
encrusting Polyandrocarpa sp. collected in the Gulf of 
California. 34 A mixture of the two compounds inhibits 
Bacillus subtilus (IOO~g. 16mm zone), Staphylococcus aureus 
(100 g, ISmm), Streptococcus pyogenes (100~g, 244mm), and 
Mycobacterium avium (100~g, ISmm); was cytotoxic towards 
LI2IO cells (1050 4.8~g/ml) and monkey kidney tissue culture 
20 
L1210 cells (1050 4.8~g/ml) and monkey kidney tissue culture 
(CV-1 cells, 200~g, 14mm); and exhibited slight antiviral 
activity against Herpes simplex virus, type 1. The 
structure elucidation was performed by spectroscopic 
analysis and chemical modifications. The assigned 
structures were remarkably similar to the acarnidines (I-~), 
natural products isolated from a sponge (Phylum-Porifera).3S 
In 1972 Faulkner had reported that crude extracts of the 
same Polyandrocarpa sp. exhibited potent antimicrobial 
activity. However, Faulkner's 1H NMR data did not 
corroborate Rinehart's published structures for the 
polyandrocarpidines. 36 Faulkner revised the structures of 
polyandrocarpidine I and II to contain the y-methylene-y-
lactam ring system as represented by (~) and (11), 
respectively. He also reported geometric isomers (1£) and 
(11) for each homolog. Soon thereafter, Rinehart 
synthesized and published the revised structures of 
hexahydropolyandrocarpidine I (11) and II (Ii) which were in 
complete agreement with Faulkner's revised structures. 37 
Halocynthia roretzi was investigated by two different 
Japanese groups. Kobayashi and co-workers isolated five 
mycosporine-like amino acids (~-~) from the ascidian. 38 
The water soluble substances were characterized by a UV-
absorption maximum in the range of 310-360 nm. 
Spectroscopic and amino acid analysis of the hydrolysis 
products were instrumental in assigning the final 
21 
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structures. Their biological role in vivo is still unknown. 
Watanabe isolated a novel lysine-derived betaine from the 
muscle of li. roretzi. 39 The structure was determined to be 
(R)-2-hydroxy-6-trimethyl ammoniohexanoate (£1). Its gross 
structure was assigned based on FDMS, FABMS, 1H and 13C NMR 
data. The positioning of the substituents was based on a 
comparison of the 13C NMR values of halocynine with those of 
laminine (l£), an analogous betaine occasionally found in 
algal extracts or in some proteins. 40 To verify their 
proposed structure, L-lysine was exhaustively methylated and 
treated with NaN02 in 0.1 M pyridine-acetic acid buffer (pH 
3.75). The spectral data of the synthetic product and the 
spectral data of the natural product were found to be 
identical. The biological role of halocynine is also 
unknown. 
Nakanishi successfully isolated and identified a bright 
yellow blood pigment, tunichrome B-1(T8-1, U) from the 
tunicate Ascidia nigra. 26 The black tunicate accumulates 
vanadium in its pentavalent state, concentrates its 10 6-fold 
and stores the metal as a complex in its reduced V(III) or 
V(IV) states. 41 V(IV) is unstable in aqueous media above pH 
2.5 prompting Nakanishi to propose a reducing nature of 
tunichrome 8-1 based on its pyrogallol moiety which is known 
to reduce V(V) to V(IV) and form complexes. 42 Tunichrome 8-
1, derived from three (3,4,S-trihydroxyphenyl) alanine 






21. R = OH 
22. R - NH3 
OH 
HO OH 








reducing pigments. Due to the instability of T8-1, the 
isolation procedure was performed in a dry 02-free Ar 
atmosphere and most of the spectral data were obtained using 
the diacetate. Tunichrome 8-1 may prove instrumental in 
deducing the biochemical role of vanadium and other trace 
metals in marine ascidians. 
Several indole-derived metabolites have been isolated 
from three ascidian species. Guyot isolated a unique 1,2,4-
thiadiazole from the dark red clustering tunicate Dendrodoa 
grossularia. 43 X-ray analysis and interpretation of the 
spectral data for the parent compound and the monoacetate 
derivative established the structure as 5-[(3-N-dimethyl-
amino)-1,2,4-thiadiazolyl]-3-indanyl methanone (£1) to which 
the name dendrodoine was given. The metabolite inhibited 
DNA synthesis when tested in vitro against the L1210 murine 
leukemia cell line. As is often the case with novel 
cytotoxic natural products, dendrodoine became the target 
molecule for a synthetic laboratory in the UK. Hogan and 
Sainsbury synthesized dendrodoine by a 1,3-dipolar addition 
reaction between indolyl-3-carbonyl nitrile (~) and N,N-
dimethylaminonitrile sulphide (~) generated in situ. 44 
Following chromatographic purification, the synthetic 
product and the natural product exhibited identical spectral 
data. In 1984, Guyot published the structure of a novel 
derivative, Grossularine (£2) from the same tunicate. 45 The 











NMR, 13C NMR and mass spectral data. No biological activity 
was reported. 
Rinehart isolated fifteen indole-derived metabolites 
(~-!l) all containing the S-carboline ring system from the 
colonial tunicate Eudistoma olivaceum.46,47 Eudistomins 
C,E,K and L (~-ll) contain the novel oxathiazepine ring 
system and exhibited potent antiviral activities against 
Herpes simplex virus, type 1 (K, 2S0ng/disk; L, 
100ng/disk).46 Their biosynthesis involves the condensation 
of tryptophan (N-2 - C-9a) and cysteine (C-l,C-10,C-ll,S-
12). In a separate communication 47 Rinehart reported the 
isolation and structure elucidation of Eudistomins 
A,D,G,H,I,J.M,N,O,P and Q (~-!£) assigning the previously 
unreported 1-pyrrolinyl-B-carboline ring system to 
eudistomins G,H,I,P and Q. These eudistomins exhibited 
modest activity against Herpes simplex virus, type 1 
(D,GtH,I,N and 0), Saccharomyces cerevisiae, a yeast (H,N,O 
and P), and Bacillus subtilus, a Gram (+) bacterium 
(D,I,N,O,P and Q). It should be noted that of the 650 
species assayed during Rinehart's 1978 Caribbean Expedition, 
E u dis tom a 0 1 i v;:.c e u m y i e 1 d edt hem 0 s t pot e n tan t i vir a 1 
compounds. 
Recently, Roll and Ireland reported the isolation of a 
novel bromoindole derivative from the Pacific tunicate 
Polycitorella mariae. 48 Citorellamine (~) exhibited potent 
antimicrobial activity against Gram (+) and Gram (-) 
bacteria, was cytotoxic in the L1210 assay (ICSO 3.7~g/ml) 
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and exhibited mild insecticidal activity against the tobacco 
budworm. Citorellamine can be biosynthesized from a gramine 
intermediate (!!) and one molecule of cysteine. 
Sesin and Ireland reported the isolation of 3,S-diiodo-
4-methoxyphenethylamine (ii) and its urea analog (~) from 
an unidentified Didemnum sp .. 49 The tunicate was found 
devoid of algal symbionts. This absence calls into question 
the biosynthetic origin of these nitrogen-containing 
compounds. However, it is not surprising that compounds of 
this type were isolated from such a tunicate since tunicates 
are known to harbor tyrosine-secreting cells and iodine 
uptake cells (See Figure S).lS The phenethylamine 
derivative (ii) proved to be a potent antifungal metabolite 
and was weakly cytotoxic in the L1210 assay (ICSO 20~g/ml). 
Ireland also published the structure of N,N'- diphenethyl 
urea (!I) from Didemnum ternatanum. It proved to be a weak 
depressant lacking acute toxicity.SO Unlike the 
aforementioned didemnid species, Didemnum ternatanum harbors 
prokaryotic algae suggesting a symbiotic biosynthesis for 
this amino acid. N,N1-diphenethyl urea (!I) may also arise 
from enzymatic manipulation of tyrosine followed by 
dimerization to form the urea. Ireland confirmed the 
structure of !I synthetically from phenethylamine and 
phosgene. 
The final group of amino acid derived metabolites from 









metabolites contain normal amide linkages. However, three 
metabolites, didemnin A-C (!a-~), possess ester linkages 
34 
and are referred to as depsipeptides. These latter cyclic 
peptides were isolated from a Caribbean tunicate of the 
family Didemnidae (Trididemnum sp.), hence the trivial name 
didemnin. 51 ,52 Acid hydrolysis followed by GC of the N-
trifluoroacetyl n-butyl ester derivatives indicated the 
presence of Leu, Meleu, Pro, Thr, Me2Tyr (all possessing the 
L configuration), and the uncommon amino acid statine. 
Another interesting structural feature was the presence of 
the hydroxyisovaleryl propionyl group. The amino acids were 
further identified by FDMS and/or ElMS of the hydrolysates 
and interpretation of the IH NMR signals. The didemnins 
inhibit the growth of both RNA and DNA viruses, are highly 
cytotoxic to L12I0 leukemia cells and protect mice against 
P388 leukemia and B16 melanoma. Specifically, didemnin B, 
which is presently in Phase 1 of clinical trials,53 has an 
1C50 O.OOII~g/ml vs. L12I0 leukemia cells, T/C up to 199 vs. 
P388 leukemia, and T/C = 160 vs. B16 melanoma. Trace amounts 
of a lower homolog of each didemnin [ D-F, (il-il)] were 
found to contain a previously unreported lower homolog of 
statine, for which Rinehart proposed the name norstatine. 
The larger of the two groups of cyclic peptides are 
those containing normal amide linkages. Lissoclinum patella 
is the source of a family of cyclic peptides,(~-Q!) 
characterized by the presence of heterocyclic thiazole and 
o 
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oxazoline amino acids and possessing varying degrees of 
activity in the L1210 murine leukemia cell assay and the CEM 
360 human tumor cell assay (See Table 1). The first report 
appeared in 1980 when Ireland and Scheuer published the 
structure of ulicyclamide (~) and ulithiacyclamide (~).54 
This was followed in 1982 with the structures of 
patellamides 1-3 (~_~).55 The structural characteristic 
of the patellamides was a fused oxazoline-thiazole ring 
system based partly on the FAB mass spectral fragmentation 
pattern and partly on the lack of homoallylic coupling 
between the alpha proton of the oxazoline ring and the alpha 
proton of the amino acid substituent at C-2 of the oxazoline 
ring. In 1983 Ireland and co-workers published the 
structures of lissoclinamide 1-3 (~-~) and the revised 
structure of ulicyclamide (~) based on newly acquired FAB 
mass spectral fragmentation data. 56 In that same year the 
Suntory group reported the structure of ascidiacyclamide 
(68) isolated from an unidentified ascidian species. 57 This 
symmetrical compound demonstrated a potent lethal effect on 
PV4 cultured cells transformed with polyoma virus (TIC 100% 
at 10~g/ml). 
The amino acid composition of the lissoclinum peptides 
was determined by interpretation of the 1H NMR, 13C NMR, 
ElMS and FABMS data with the latter two techniques 
instrumental in assigning the amino acid sequence. The 
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comparing the GC retention times of the methyl ester 
trifluoroacetyl derivatives of the total hydrolysis products 
with standards. The majority of the amino acids were found 
to possess the L configuration. Acid hydrolysis caused 
racemization of the thiazole amino acids. To circumvent 
this problem Biskupiak and Ireland published a general and 
mild method for determining the chirality of thiazole amino 
acids using singlet oxygen (102)58. 
In 1986 Sesin and Ireland published the revised 
structures of the patellamides A-C (~-~) based on FAB 
MS/MS daughter ion analysis of a tripeptide obtained from 
hydrolysis of patellamide Band 2D COSY-45 data. 59 
Concurrently, the revised structures were confirmed in an 
elegant synthesis performed by Professor Shioiri. 60 The 
COSY 45 technique was also useful in assigning the 
structures of three new minor Lissoclinum metabolites (~­
~), all containing threonine. 59 It is possible that 
prelissoclinamide 2 (~), prepatellamide-B-formate (Q1) and 
preulicyclamide (~) are precursors and that the final step 
in the biosynthesis of the lissoclinum peptides is formation 
of the oxazoline ring. 
The remaining secondary metabolites isolated from 
marine tunicates represent four major groups: sterols, 
terpenes, quinones (all biosynthesized from acetyl CoA) and 
those of questionable origin. Djerassi reported the 




















steroids (IQ) and 4 -methyl sterols (21).61 In all cases 
structure elucidation was based on a comparison of their 
spectral data (UV, CD, NMR and mass spectral fragmentation 
patterns) with that of known compounds. The origin of these 
uncommon sterols is an intriguing question. Algal symbiosis 
was impossible because the ascidian, upon careful inspection, 
was found devoid of all algal symbionts. In the biosynthesis 
of regular sterols, 4a-methyl sterols (21) are intermediates. 
The complexity of the mixture of 4a-methyl sterols (21) and 
the absence of main sterols with a cholesterol side chain 
suggested that Ascidia nigra is unable to synthesize sterols. 
Therefore, the 4a-methyl sterols (21) were most likely of 
planktonic origin. Coprostanol is ubiquitous in the marine 
environment leading Djerassi to propose a dietary origin for 
the novel coprostanols (~) with possible chemical 
modification occurring in the ascidian's digestive tract. 
Guyot isolated two different types of sterols from two 
solitary tunicates collected on the French coast- Phallusia 
mamillata and Ciona intestinalis. Column chromatography 
yielded a mixture whose characteristic features were those 
of sterol peroxides (2£-~).62 All four 9(11)-unsaturated 
sterol peroxides were obtained from £. mamillata. £. 
intestinalis yielded only sterol peroxide 2£. Structure 
elucidation was based on spectral data and confirmed by 


















their corresponding trienes (~-~) and are generated by the 
4+2 cyclo-addition of 02 across the 5,7 diene. To eliminate 
the possibility that these compounds were artifacts, Guyot 
performed the extraction procedure in the dark and obtained 
the same results. The second class of sterols isolated from 
the same two ascidians (f. mamillata, k. intestinalis) are 
those possessing hydroperoxides. Guyot isolated 24-
hydroperoxy-24-vinyl cholesterol (~) and confirmed the 
structure by reducing it to the known 24-hydroxy-24-vinyl 
cholesterol (saringosterol, al) using LiA1H4. 63 This 
compound represents 0.004% of the total extract. Therefore, 
to obtain a sufficient amount of material for testing, 
fucosterol (~) was oxidized by 102 oxidation (02, hv) 
yielding the derived product in one step.64 The 
hydroperoxide exhibited cytotoxic activity against the L1210 
murine leukemia cell line (ICSO 2~g/ml), spleen lymphocytes 
without mutagens (ICSO l~g/ml) and spleen lymphocytes with 
Concanavalin A (ICSO l~g/ml). 
The steroidal composition of ascidian membranes is 
quite unique. Morris and co-workers investigated three 
tunicate species and found a preponderance of Sa-stanols 
(~) and their corresponding ~S-sterols (ai).6S The 
saturated ring sterols are considered the intermediate in 
the conversion of DS-sterols to D7-sterols (~).However, the 
latter compounds were present in only 1% of the total 












selectively concentrate certain metal ions from sea water 66 , 
Morris concluded that the 8 5-sterols (a!) are involved in 
the specialized properties of membranes. 
A series of carotenoids have been isolated from two 
Japanese tunicate species. Matsuno and Ookubo reported the 
structure of halocynthiaxanthin (86)67 and mytiloxanthinone 
(~)68 from Halocynthia roretzi. Amarouciaxanthin A (88) + 
B (89) were isolated from Amaroucium pliciferum. 69 These 
compounds may represent metabolic products from fucoxanthin 
(~), a carotenoid found in phytoplankton and sea weeds on 
which the tunicates feed (See Figure 6).70 Guyot isolated 
sidnyaxanthin from the bright orange colonial tunicate 
Sidnyum argus. 71 Sidnyaxanthin was structurally identical 
to amarouciaxanthin B (89). All the carotenoids mentioned 
above were obtained as bright red crystals. Assignment of 
their final structures was based on spectral interpretation 
and chemical transformations. They exhibited no biological 
activity. 
Hydroquinone derivatives offer protection against 
leukemia and tumor development in test animals. Wells 
isolated geranyl hydroquinone (~), its chromenol (~) and 
an unidentified ten-membered ring ether derivative from the 
Australian tunicate Aplidium cavernosa. 72 Following a 
thorough investigation of another aplidium species (Aplidium 
californicum), Howard isolated three simple prenylated 















Figure 6 . Metabolic pathway of fucoxanthin 
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hydroxy-2,2-dimethylchromene (i!) and prenylquinone (~).73 
The structures of all three compounds were secured by 
synthesis. Prenylhydroquinone (~) exhibited in vivo (mice) 
activity against P388 lymphocytic leukemia (T/C = 138 at 
3.12mg/kg). Furthermore, prenylhydroquinone (~) and its 
chromenol (i!) inhibited the mutagenic effects of 
benzo(a)pyrene, aflatoxin B, and UV light on Salmonella 
typhimurium (modified Ames Assay). Compounds ~ and i! also 
exhibited antioxidant properties. 
Sesin and Ireland isolated four novel cytotoxic 
metabolites (~-~) from the encrusting ascidian Didemnum 
voeltzkowi.74 Voeltzkowinols A,B,C,D exhibited varying 
degrees of activity in the L1210 assay (voeltzkowinol A: 3.9 
~g/ml; voeltzkowinol B & C: 5.6 ~g/ml; voeltzkowinol 0: 0.56 
~g/ml) and are structurally similar to compound(100) also 
isolated from a didemnid tunicate. 75 
Rinehart isolated a metabolite from an orange-flecked 
Aplidium sp. which is biosynthesized from an acetyl CoA 
derivative (diterpene) and an amino acid (serine minus its 
carboxyl group).76 The compound, appropriately called 
aplidiasphingosine (101), was identified by spectral 
interpretation and chemical modification. Its 
stereochemistry was deduced based on an asymmetric synthesis 
in which the key reaction was the Sharpless asymmetric 
epoxidation and a 13C NMR study of sphingosine relatives. 77 










~g/12.7mm disc) against Gram (+) bacteria (Bacillus subtilis, 
24mm; Sarcina lutea, 20mm), Gram (-) bacteria (Klebsiella 
pneumoniae, 21mm; Mycobacterium avium, 21mm), and fungi 
(Candida albicans, slight), and was cytotoxic towards KB 
(ICSO 8.3~g/ml) and L1210 (ICSO 1.9~g/ml) tumor cells. 
It should also be noted that tunicates possess 
significant concentrations of riboflavin (102), 
isoxanthopterin (103) and 2-amino-4 hydroxypteridine (104) 
suggesting that they serve an important role in the nutritive 






THE CHEMISTRY OF SOME PACIFIC TUNICATES 
Rinehart 32 and Weinheimer 33 defined marine tunicates as 
potential sources of biologically-active compounds. This 
prompted Dr. Ireland to pursue a systematic investigation of 
Pacific ascidians. During my tenure as a graduate student I 
have isolated several biologically-active compounds from the 
following Pacific tunicates: an unidentified didemnid, 
Didemnum voeltzkowi and Lissoclinum patella. Most of the 
compounds isolated from these tunicates are biosynthesized 
from amino acids. These nitrogen-containing metabolites 
possess varying degrees of cytotoxic activity in the L1210 
murine leukemia cell assay and the CEM 360 assay. One of 
the compounds (3.S-diiodo-4-methoxyphenethylamine, ii) 
exhibited significant antifungal activity against the yeast 
Candida albicans. ~. voeltzkowi produced four non-
nitrogenous prostaglandin-like compounds that also 
demonstrated good activity in the L1210 assay. The following 
sections will discuss the isolation and structure 
elucidation of the active metabolites from each tunicate. 
The Chemistry of an Unidentified Tunicate 
An unidentified didemnid tunicate 79 was collected from 
the exposed rocks at the northwest end of Cocos Lagoon, Guam 
where it was found as an encrusting species. The ascidian 
was collected at two different times,(1981, 1982). Both 
collections produced the same chemistry. 
55 
The ascidian was kept frozen until work-up. The first 
step in the isolation procedure was lyophilization of the 
frozen tissue. The freeze dried tissue (116g) was placed in 
a soxhlet extraction apparatus and exhaustively extracted 
with pet ether, CC14 and then CHC13' The extracted tissue 
was then placed in a 1 liter flask containing MeOH and 
allowed to extract overnight. Initial testing of each crude 
extract in the L1210 assay indicated borderline activity 
(10 ~g/ml) in the CHC13 extract. 
While the CHC13 extract was cooling at room temperature 
a brown solid, 3,5-diiodo-4-methoxyphenethylamine (!il (450 
mg 0.4% dry weight) precipitated from solution as the HCl 
salt. Upon refrigeration of the CHC13 extract a second 
metabolite, subsequently identified as the urea analog (![), 
precipitated from solution. Column chromatography of the 
CHC13 extract (Silica gel 60, 95:5:0.7 EtOAc/MeOH/NH40H) 
yielded 3 fractions. The more polar fraction appeared as a 
light red liquid and exhibited good activity in the L1210 
assay (3.4 ~g/ml). Unfortunately, the sample weight was 
approximately 1 mg and with the unlikelihood of obtaining 
more freeze-dried tissue attention was focused on compounds 
li and ![. 
The major metabolite (li) was assigned the molecular 
formula C9H11NOI2 (HRMS: obs 402.8929, calc. 402.8941) 
56 
indicating four degrees of unsaturation. The 13C NMR 
spectrum contained signals for 6 sp2 carbons: 157.1 (s), 
139.7 (d, 2C), 137.7 (s), 91.5 (s, 2C). The lack of a 
carbonyl stretch between 1800-1600 cm- l , a UV Amax of 268nm 
and IR stretches at 1600, 1460, 860 and 710 cm- l suggested 
the presence of a substituted benzene ring. Present in the 
IH NMR spectrum was an A2B2 spin system [3.03 (t, 2H, J = 7 
Hz); 2.86 (t, 2H, J = 7 Hz)] assignable to the four 
methylene protons of a phenethylamine. Signals in the IH 
and 13C NMR spectra defined the following substituents 
attached to the benzene ring: one methoxyl (IH: 3.73 ppm; 
13C: 157.1 ppm), two iodines [13C: 91.5 (s, 2C)] and two 
degenerate protons [IH: 7.76 (s, 2H); 13C: 139.7 (d, 2C)]. 
Placement of the substituents about the ring was based on 
the following arguments: the final structure should be 
symmetrical based on the degeneracy of the aromatic proton 
signals. The methoxyl and iodine atoms were placed in the 
para and meta positions,respectively, to mimic the structure 
of thyroxin (~). 
Instrumental in assigning the final structure was 
complete analysis of the major fragment ions in the EI mass 
spectrum (Figure 7). Present is the molecular ion at mlz 
403 that peak matched to within 3 mmu (or 3 ppm) of its 
calculated molecular weight. 6-cleavage of the side chain 
results in formation of the base peak at mlz 373. This ion 
can easily be converted into the highly stable tropyllium 
57 
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Figure 7. ElMS fragmentation pattern of 45 
ion. Para substituted aniso1es have been shown to undergo 
alpha c1eavage. 80 This cleavage results in a mlz 359 ion. 
The ion at mlz 386 results from the expulsion of NH3 from 
the parent molecule. 
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To confirm placement of the substituents about the ring 
the natural product was synthesized. The first synthetic 
route involved decarboxylation of 3,5-diiodo-tyrosine 
followed by methylation of the phenol to yield the desired 
product (Figure 8). The two methods used to decarboxylate 
the starting material proved to be exercises in futility. 
Enzymatic decarboxylation using tyrosine decarboxy1ase 81 was 
hampered by poor solubility of the substrate in the acetate 
buffer. To alleviate this problem the substrate was first 
dissolved in a 50:50 mixture of acetone and water. The 
acetone was removed by heating on a steam bath. To maintain 
solubility 2 drops of concentrated Tween-80 (surfactant) 
were added immediately. The solution was cooled to room 
temperature. Pyridoxal 5'-phosphate and tyrosine 
decarboxylase were added to the flask. The flask was 
stoppered with a wad of cotton and left to react in an oil 
bath set at 37°C. High-voltage electrophoresis of the 
enzymatic reaction mixture indicated the presence of only 
starting material. Evidently, 3,5-diiodo-tyrosine is not an 
acceptable substrate for tyrosine decarboxylase. As an 
alternative method catalytic decarboxylation using Cu(OAc)2 
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Figure 8. Decarboxylation of tyrosine 
59 
complex involving the amine and the carboxyl group. The 
complex is subsequently degraded by heating in DMSO. All 
attempts to decarboxylate 3,5-diiodo-tyrosine failed. 
60 
Several attempts to methylate the phenol (CH2N2,MeOH) prior 
to the decarboxylation step also failed prompting the 
formulation of an entirely new reaction sequence using 
tyramine (105) as the starting material. This new reaction 
sequence involved methylation of the phenol followed by 
electrophilic attack by 1+. The amine was blocked to 
prevent N-methylation. This was accomplished by acetylating 
the nitrogen with acetic anhydride in H20. The order of 
methylation and iodination was very critical. Methylation 
followed by iodination resulted in the formation of mono-
iodinated products. Presumably, the first iodo group 
directs the methoxyl group such that the methyl sterically 
hinders approach of the second iodide atom. The successful 
reaction sequence is shown in Figure 9. Tyramine was first 
acetylated using AC20/H20, affording N-acyl tyramine (106). 
Compound 106 was then iodinated using ICl and glacial acetic 
acid 83 forming intermediate 107. The hydroxyl group is a 
much stronger ortho director than an alkyl group. Therefore 
electrophilic substitution of compound 106 resulted in the 
substitution pattern as shown for compound 107. Methylation 
of the phenol using NaH and dimethyl sulfate yielded 108. 
Attempts to methylate with CH2N2/MeOH were unsuccessful 



















Figure 9. Synthesis of 3,S-diiodo-4-methoxyphenethylamine 
Acid hydrolysis of 108 (6N HC1, threaded test tube, 110°C, 
12 h) followed by column chromatography (Silica gel, 
70:20:10 CHC13/MeOH/NH40H) yielded 3,5-diiodo-4-
methoxyphenethylamine (~) as the HCl salt in 80% yield. 
The spectral data of the synthetic product and the natural 
product were identical. 
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The minor metabolite, 3,5 diiodo-4-methoxyphenethylurea 
(~), represented 0.01% of the total dry weight. It was 
assigned a molecular formula C19H20N203I4 (HRMS: obs. 
831.7699, calc.831.7675). The 1H NMR of compound ~ 
contained signals directly assignable to a phenethylamine 
unit [87.56 (s, 2H); 3.62 (s, 3H); 3.08 (dt, 2H, J = 7, 6 
Hz); 2.49 (t, 2H, J = 7 Hz)] and a new signal at 5.78 ppm 
(t, J = 6 Hz) assigned to the NH proton of the urea. The 
13C NMR spectrum contained only 8 signals, seven of which 
were consistent for the phenethylamine unit (8157.8 (s), 
140.2 (d, 2C), 139.6 (s), 91.0 (s, 2C), 60.1 (q), 40.4 (t), 
34.1 (t), and the eighth signal, a singlet at 156.6 ppm, 
which was assigned to a urea carbonyl. These pieces of data 
suggested that the urea was symmetrical. 
Again, complete analysis of the major fragment ions 
(Figure 10) in the EI mass spectrum was instrumental in 
confirming the structure. A molecular ion appeared at mlz 
832 which peak matched to within 3 mmu (or 3 ppm) of its 
calculated molecular weight. Loss of an iodide atom results 
in the formation of an ion at mlz 705. Baldwin has 
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Figure 10. ElMS fragmentation pattern of 46 
54 
demonstrated that urea derivatives undergo four major modes 
of fragmentation as illustrated in Figure 11. 84 Pathways 
(3) and (4) account for the formation of the radical cations 
at mlz 429 and 403. Previously, N,N'-diphenethylurea was 
isolated from a didemnid tunicate 50 , suggesting that the 
urea analog is a natural product and not an artefact. 
3,5-0iiodo-4-methoxyphenethylamine (~) exhibited 
moderate activity in the L1210 murine leukemia cell assay 
(IC50 20~g/ml). When tested irr vitro against the yeast 
Candida albicans it proved to be a potent antifungal 
metabolite. This observation was very rewarding because 
there are very few marine natural products that successfully 
eliminate yeast infections. Compound ~ was also mildly 
active against gram(+) and gram(-) pathogens. In sharp 
contrast, the urea analog exhibited no biological activity. 
These two metabolites are also interesting from a 
biosynthetic viewpoint. Several nitrogen-containing 
metabolites, such as the Lissoclinum peptides (ii_Qi)54-55 
and N,N'diphenethylurea (!I), have been isolated from 
didemnid tunicates harboring unicellular prokaryotic algae. 
As discussed earlier, it is theorized that the symbiotic 
algae may be responsible for the biosynthesis of these 
compounds. However, compounds ~ and ~ were isolated from 
a didemnid species devoid of all algal symbionts. Therefore 
compounds ~ and ~ are of dietary origin or are 











Figure 11. Fragmentation patterns for urea derivatives 
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66 
secreting cells and iodine uptake cells in the endostyle of 
ascidians 2 strongly suggests that the tunicate is 
responsible for their biosynthesis. 
The Chemistry of Didemnum voeltzkowi 
Didemnum voeltzkowi was collected on the main fringing 
reef of Suva Harbor, Fiji, where it was found as an 
encrusting species on coral and coralline algae. The 
tunicate harbors symbiotic algae as defined by the speckling 
of green dots seen throughout the test of the organism. 
Initial testing of a crude methanolic extract in the L1210 
assay gave a cytotoxicity value of 5.5~g/ml. This value is 
indicative of borderline activity; however, for a crude 
extract in which many of the components are salts and lysed 
cells it was encouraging. 
Isolating the active metabolites proved to be very 
challenging due to their propensity to decompose. Leaving 
the extract on the lab bench in a small amount of MeOH for 
one hour or overnight storage in a refrigerator was 
sufficient to initiate decomposition of the active 
compounds. All chromatographic techniques were performed in 
the dark and once isolated the pure compounds were dissolved 
in MeOH and stored in a freezer. 
The general protocol for initial extraction of freeze-
dried tissue was switched from the high-temperature soxhlet 
extraction procedure, which became unappealing due to its 
ability to thermally decompose compounds, to the more gentle 
67 
but equally effective Kupchan fractionation scheme. 85 A 
modification of the latter technique proved to be effective 
in isolating the active components from Didemnum voeltzkowi. 
The freeze-dried tissue (625 g) was blended with 1.25L of 
MeOH. The homogenate was divided into three equal portions. 
Each portion was transferred to a 1L erlenmeyer flask and 
extracted overnight. The solvent was removed irr vacuo. The 
residue was redissolved in MeOH and partitioned with CHC13 
(3 x 125 ml). Three of the four cytotoxic metabolites were 
strongly UV-active; the fourth metabolite appeared as a dark 
yellow spot on the TLC plate. Examination of the CHC13 and 
MeOH fractions by TLC (Silica gel, EtOAc/TMP 8:2) indicated 
that all four compounds were concentrated in the MeOH 
fraction. A BuOH/H20 partition of the methanolic fraction 
isolated the metabolites from the salts and lysed cells. 
The butanol fraction was chromatographed on a 6 ft. Sephadex 
column (LH-20, MeOH:CHC13 1:1) yielding a light yellow oil 
that tested at 2.7 ~g/ml (L1210 assay). This oil was 
further purified by HPLC (~partisil, EtOAc/TMP 8:2) to 
yield voeltzkowinol A (~, 0.002% dry weight), B (iI, 0.007% 
dry weight), C (~, 0.006% dry weight) and 0 (~, 0.02% dry 
weight) in order of increasing polarity. 
Voeltzkowinol B (iI) was assigned the molecular formula 
CI1H1404 (HRElMS: obs. 210.0893; calc. 210.0888) indicating 
5 degrees of unsaturation. Acetylation of voeltzkowinol B 










294; IH NMR: 02.09 (s, 3H), 2.04 (s, 3H)] indicating the 
presence of two 1° and/or 2° hydroxyls in the molecule. An 
IR stretch at 1704 cm- 1 and a UV max of 231 nm suggested 
the presence of a cyclopentenone ring system. The NMR 
spectral data of voeltzkowinol B is shown in Figure 12. 
Present in the IH NMR spectrum is an isolated AB spin system 
[06.25 (d, IH, J = 6 Hz), 7.51 (d, IH, J = 6 Hz)] for the a 
and 8 protons of the cyclopentenone and two isolated AB spin 
systems [03.96 (d, IH, J = 12.6 Hz), 4.24 (d, IH, J = 12.6 
Hz); 3.59 (d, IH, J = 10.5 Hz), 3.69 (d, IH, J = 10.5 Hz)] 
for two primary alcohols. Also present are four olefinic 
signals [06.38 (d, IH, J = 11.2 Hz), 6.65 (ddd, IH, J 
10.6, 11.2, 16.5 Hz), 5.31 (d, 1H, J = 16.5 Hz), 5.21 (d, 
IH, J = 10.6 Hz)] defining a conjugated 1,1 disubstituted 
diene. The multiplicities of the olefinic carbon signals 
[0136.1 (t), 133.7 (d), 133.5 (d), 119.8 (s)] corroborated 
this assignment. Placement of substituents about the 
cyclopentenone ring system was based on the multiplicities 
and chemical shifts of the remaining signals in the 1H and 
13C NMR spectra. Present in the 13C NMR spectrum is a 
singlet at 82.2 ppm and a doublet at 53.0 ppm indicating 
that there is only one additional proton attached to the 
cyclopentenone ring. This proton appears as a sharp singlet 
at 3.88 ppm necessitating that it be placed adjacent to the 
carbonyl. 




oxygen and a proton. The IR spectrum was transparent in the 
region defining a c-o stretch for an ether (1300-1000 cm- 1) 
implying the presence of an additional hydroxyl group. 
Recalling that acetylation of voeltzkowinol B produced a 
diacetate suggested that the third hydroxyl was tertiary. 
The diene carbon signals showed no appreciable polarization 
due to the attachment of a heteroatom indicating that one of 
the diene substituents must be a primary alcohol and not the 
tertiary alcohol. Therefore the tertiary alcohol had to be 
placed on the ring carbon adjacent to the methine. 
There are two possible ways of constructing 
voeltzkowinol B as shown in Figure 13. Structure B was 
chosen based on the multiplicity of the methinyl proton at 
C-5 [63.88 (s)] and the well-defined AB system assigned to 
the nonallylic primary alcohol [63.69 (d, 1H, J = 10.5 Hz, 
3.59 (d, 1H, J = 10.5 Hz]. If structure A was correct the 
methinyl proton should appear as a triplet and the well-
defined AB signal for the nonallylic hydroxyl methylene 
protons should appear as a doublet of quartets. Additional 
evidence confirming the assignment of voeltzkowinol B was 
obtained from chemical modifications as described below. 
Voeltzkowinol C (98) was isomeric with voeltzkowinol B 
(iL) and exhibited virtually identical spectral data. 
Acetylation of voeltzkowinol C gave a diacetate (110) 
indicating the presence of two primary alcohols. The 1H NMR 
spectrum of 98 is shown in Figure 14. Present are peaks for 
~OH 
OH 
o H ~\ OH ~ H ~H 
A B 
Figure 13. Partial structures and possible structures 



















the cyclopentenone ring [87.58 (d, 1H, J = 6 Hz), 6.15 (d, 
1H, J = 6 Hz)] and the diene side chain [86.41 (m, 1H, J = 
16.4, 16, 10 Hz), 6.26 (d, 1H, J = 16 Hz), 5.27 (d, 1H, J = 
16.4 Hz), 5.16 (d, 1H, J = 10 Hz)]. The 1H NMR spectrum 
differed from that of voeltzkowinol B in the region between 
3.5-4.5 ppm (Figure 15). This region contains the signals 
for the two primary alcohols and the methine proton at C-5. 
Due to the allylic nature of the primary alcohol at C-6 it 
was assigned to the downfield spin system centered at 4.1 
ppm. Present in the 1H NMR of voeltzkowinol C is the AB 
spin system for the allylic primary alcohol. Missing is the 
AB spin system for the primary alcohol at C-4. Instead one 
finds a broad singlet at 3.5 ppm that integrates for three 
protons. This signal was assigned to the methinyl proton at 
C-5 and the two primary alcohol protons at C-4 suggesting 
that voeltzkowinol Band voeltzkowinol C were epimeric at C-
4 or C-5. 
The stereochemical relationship between the diene side 
chain and the hydroxyl substituents at C-4 was solved by the 
following chemical analysis. Allylic oxidation of 
voeltzkowinol Band C should yield the five or six-membered 
ring lactone depending on which alcohol attached at C-4 is 
cis to the diene side chain. The results of the chemical 
study are shown in Figure 16. Allylic oxidation of 
voeltzkowinol B with Mn02 in CH2C12 afforded the gamma 
lactone (lll) as the only product in good yield. The first 
I I , , ! I ! It' I , , ! ! I I I 
4 3 
Figure 15. IH NMR of voeltzkowinol B (top) and 
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Figure 16. Allylic oxidation of Band C 
intermediate formed is the aldehyde which spontaneously 
cyclizes to form the gamma-lactol. Because of the allylic 
nature of the lactol it is further oxidized to the lactone 
[ElMS: m/z = 206; lR: 1750, 1719 cm- 1]. This chemistry is 
consistent only if the 3° alcohol and the diene side chain 
at C-5 are cis to one another. Conversely, allylic 
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oxidation of voeltzkowinol C, under identical conditions, 
produced the aldehyde [112, ElMS: m/z = 208, 1H NMR: 69.46 
(s, 1H), lR: 1720, 1680cm- 1] indicating that the 3° alcohol 
and the side chain are now trans to one another. The lack 
of formation of the 6 -lactone can be explained kinetically 
and thermodynamically. House states that the rates of ring 
closure follow the order: 3 > 5 > 6 > 7 > 4,8.86 In the 
voeltzkowinols the 3° alcohol has fewer degrees of rotation 
than the 1° alcohol. Therefore, the 3° alcohol spends more 
time in close proximity to the aldehyde allowing it to react 
quicker (lower ~G ) and more often. Constructing a model 
with the 1° alcohol or 3° alcohol cis to the diene side 
chain is also very informative (Figure 17). When the 3° 
alcohol is cis to the diene the repulsive forces due to 
electrostatic interactions between the oxygen atoms of the 3° 
alcohol and the aldehyde result in an orientation that 
strongly favors lactonization. The model in which the 1° 
alcohol and the diene are cis to one another immediately 
demonstrates the spatial problems arising from the 
additional degrees of freedom. Furthermore, the 
B 
c 
Figure 17. Postulated intermediates in the allylic 
oxidation of voeltzkowinol Band C 
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intermediate formed by initial attack of the primary 
hydroxyl on the aldehydic carbon exists in the unfavorable 
boat conformation. It is important to note that the 
equilibrium could be shifted from the aldehyde (ll£) to the 
8-lactol [113, ElMS mlz = 208; lH NMR 85.41 (s, lH)] using 
MeOH. The hydroxyl proton ;s exchanging at a rate that 
enhances nucleophilicity of the oxygen. Protonation of the 
carbonyl causes increased electrophilicity of the carbonyl 
carbon. The combination of these two factors may influence 
formation of the 8-lactol. 
The diene side chain was drawn as shown based on 
spectral comparison of a structurally similar compound (100) 
also isolated from a didemnid tunicate in which the diene 
was assigned by x-ray analysis. 75 Since the lH NMR spectrum 
of compound 100 and voeltzkowinols Band C were very similar 
it was proposed that the diene systems possessed the same 
configuration. 
To support this argument a 2D nuclear Overhauser effect 
experiment (NOESy)87 was performed on voeltzkowinol B. The 
nOe is a dipole-dipole phenomenon in which magnetization is 
transferred through space from one proton to another proton. 
The efficiency of this cross-relaxation falls off to the 
sixth power of the distance between the protons. In 
general, the nOe is detectable for protons separated 
spatially by ~4 Angstroms. In the 2D NOESY experiment all 
protons are preirradiated by a 90° lH pulse. This is 
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followed by a delay time that allows for the exchange of 
magnetization between dipole-dipole coupled protons. This 
delay time is set to the average T1 value for the protons of 
interest. A disadvantage of the NOESY experiment is the 
appearance of crosspeaks in the 20 NOESY map for scalar 
coupled protons. To circumvent this problem the final delay 
is randomly varied by 20 msec. This, theoretically, reduces 
the scalar couplings. Normally, a correlation experiment 
(COSY) used to assign protons that are scalar coupled is run 
for comparison. Both experiments (NOESY, COSY) were 
performed on voeltzkowinol B (Figure 18). Since the 
interpretation of the results involves a direct comparison 
of the two experiments, all IH pulses in both experiments 
were set to promote a 90 0 phase shift. The interpretation 
of both contour maps is essentially the same. The diagonal 
represents the 10 IH NMR spectrum. Crosspeaks that lie 
symmetrically above and below the diagonal can be thought of 
as occupying two corners of a box. Where the remaining two 
corners fallon the diagonal represents the protons that are 
scalar coupled (COSY) or dipole-dipole coupled (NOESY). If 
the assignment of the diene is correct, crosspeaks should 
appear in the NOESY map correlating the methinyl proton at 
C-5 (03.88 ppm) and the olefinic proton at C-8 (06.65 ppm). 
The arrows in the NOESY map indicate the presence of these 
two crosspeaks. The protons at C-5 and C-8 are separated by 
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Figure 18. 20 NOESY (top) and COSY (bottom) spectra 
of voeltzkowinol B 
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could represent 5JH_H. However, crosspeaks for this scalar 
interaction are absent in the COSY map. 
Additional evidence supporting the attachment of the 
diene side chain at C-5 is the detection of W coupling (2.2 
Hz) in the Y-lactone between the methinyl proton at C-5 and 
the olefinic proton at C-7. This coupling was not observed 
in the natural product. 
Voeltzkowinol 0 (~) was also found to be isomeric with 
voeltzkowinol B. The UV spectrum showed two absorption 
maxima at 233 (s 11,000) and 307 (s 10,000) nm. The UV 
absorption at 233 nm along with the 1H and 13C NMR data [lH: 
66.29 (d, 1H, J = 6 Hz), 7.40 (d, 1H, J = 6 Hz); 13C: 6199.1 
(s), 161.5 (d), 128.4 (d)] established the presence of the 
cyclopentenone ring. The UV absorption at 307 nm and an IR 
stretch at 1680 cm- 1 indicated that the diene had moved into 
conjugation with the cyclopentenone. The 1H NMR spectrum is 
shown in Figure 19. Absent is the sharp singlet at 3.88 ppm 
that was previously assigned to the methinyl proton at C-5. 
Also missing are the two terminal methylene protons at 5.1 
and 5.2 ppm. Replacing them are signals defining a trans 
disubstituted double bond [67.83 (dd, 1H, J = 16, 1.3 Hz), 
6.52 (dq, 1H, J = 16,7 Hz), 1.90 (dd, 3H, J = 7, 1.3 Hz)]. 
The 13C NMR spectrum shows signals for a new tetra 
substituted double bond conjugated to a carbonyl. The a-
and 8-carbons appear at 134.2 and 146.8 ppm respectively. 


















between 50-55 ppm and an upfield shift of the pentenone 
carbonyl (6199 ppm) supporting conjugation of the diene to 
the carbonyl. 
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The presence of two primary alcohols and one tertiary 
alcohol was confirmed by interpretation of the spectral data 
[IR: 3600cm- 1; 13C NMR: 682.0 (s), 68.2 (t), 58.3 (t); 1H 
NMR: 84.83 (d, 1H, J = 11.8 Hz), 4.57 (d, 1H, J = 11.8 Hz), 
3.90 (d, 1H, J = 12 Hz), 3.69 (d, 1H, J = 12 Hz)] and by 
acetylation of voeltzkowinol D (AC20, pyridine) to a 
diacetate [114, ElMS: mlz = 294; 1H NMR: 62.03, (s, 6H)] and 
a small amount of a triacetate [115, ElMS: mlz = 336; 1H 
NMR: 82.06 (s, 3H), 2.04 (s, 3H), 2.02 (s, 3H)]. 
The tetra substituted double bond was assigned the E 
geometry based on the following argument. The gamma 
position of a dienone is normally a shielded position. The 
unusual downfield shift of the gamma proton at 7.83 ppm 
implies that it lies in the deshielding cone of the 
carbonyl; a situation that could exist only if the 
tetrasubstituted double bond adopts the E geometry. This 
assignment is in complete agreement with Kitagawa's 
assignment of the diene geometry in claviridenone 1 (116) 
and 3 {1lI).88 In claviridenone 1, the gamma proton appears 
at 7.62 ppm whereas in claviridenone 3 the same proton 
appears at 6.74 ppm. Kitagawa also attributed this anomaly 
to the anisotropy effect from the carbonyl. The 7-ene 








on the 16 Hz coupling constant between H-7 and H-8. This 
was also in complete agreement with the analogous coupling 
constants in claviridenone 1 and 3. 88 
87 
With the gross structures of voeltzkowinol B, C and D 
secured, all that remains is the determination of their 
relative and absolute stereochemistry. The allylic 
oxidation of Band C only established that the 3° alcohol is 
cis to the diene side chain in B and trans to the diene side 
chain in C. The stereochemistry as illustrated in the 
structures for B (~) and C (~) is purely arbitrary. The 
enantiomers of B (118) and C (119) could also be drawn. 
The proton at C-5 (B and C) should be very labile 
making C-5 the more reactive center. Removal of the proton 
at C-5 would result in the formation of a carbanion 
stabilized by the neighboring diene system and carbonyl. 
Reprotonation could then occur from either face yielding B 
and/or C. Therefore, it is theorized that the epimeric 
center is C-5 and not C-4. The lability of the proton at C-
5 provides a handle for proving this theory. Epimerization 
of this center should be effected under acidic (O.lM HCOOH) 
or basic (1% Na2C03' MeOH) conditions. Assuming that 
voeltzkowinol B (~) is the starting material, the reaction 
mixture should contain B (~) and C (~) or the enantiomer 
of C (119). A comparison of the optical rotation of the 
reaction product with that of the natural product should 
establish the relative stereochemistry of Band C. Under 
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the reaction conditions only C-5 should epimerize. 
Therefore, if the optical rotation of voeltzkowinol C 
(obtained from the reaction mixture) is identical to that of 
the natural product then C is structure ~ and Band Care 
epimeric at C-5. If the optical rotations are different 
then Band C are epimeric at C-4. 
To determine absolute stereochemistry requires that the 
absolute configuration of one of the chiral centers be 
known. It should be possible (under stronger conditions) to 
cross-conjugate the diene and the carbonyl of B (or C) and 
form D (~) or its enantiomer (120). If the absolute 
stereochemistry of D and the relationship of B (or C) and D 
at C-4 can be established then voeltzkowinols B, C and D can 
be drawn with absolute stereochemistry. 
Claviridenone 4 (lll) is a structurally similar 
compound to voeltzkowinol D. A Japanese group established 
the absolute stereochemistry of (lll) by the following 
procedure (Figure 20).89 Reduction of III with NaBH4 in 
MeOH at room temperature yielded two epimeric alcohols (122) 
and (123). The relative stereochemistry at C-9 and C-12 was 
determined by evaluation of their 1H NMR spectra and also by 
the observation of intramolecular H-bonding between the 
hydroxyl proton at C-9 and the carbonyl oxygen at C-12. 
Compounds 122 and 123 were treated with p-
bromobenzoylchloride in CC14 in the presence of 
triethylamine and N,N-dimethylaminopyridine. Analysis of 
89 
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the CD spectra of the resulting p-bromobenzoates (124) and 
(125) established the absolute stereochemistry at C-9 and C-
12. This methodology should be applicable to voeltzkowinol 
D. 
Voeltzkowinol A (~) represented the least polar 
metabolite in the family. It was assigned a molecular 
formula C11H1203 (HREIMS: obs. 192.0786, calc. 192.0783) 
indicating six degrees of unsaturation. Acetylation of ~ 
yielded a monoacetate [126, 1H nmr: 82.10 (s, 3H)] 
indicating the presence of one primary alcohol. A UV Amax 
of 270 nm and 6 olefinic signals in the carbon spectrum 
[8155.9 (d), 152.1 (s), 147.9 (d), 128.8 (s),127.3 (d), 
117.9 (s)] indicated the presence of a conjugated triene. 
The absence of a carbonyl stretch in the IR spectrum 
established that voeltzkowinol A was tricyclic. Present in 
the 1H NMR spectrum is an isolated AB spin system [85.89 (d, 
1H, J = 6 Hz), 7.71 (d, 1H, J = 6 Hz)] reminiscent of the 
cyclopentenone, an AB spin system [04.67 (d, 1H, J = 15 Hz), 
4.92 (d, 1H, J = 15 Hz)] for one primary alcohol, and a 
sharp singlet at 6.93 ppm assignable to an enolic olefinic 
proton. Also present is a new spin system comprised of a 
methine bearing oxygen at 4.3 ppm (dd, 1H, J = 9.9, 5.7 Hz), 
two allylic methylene protons at 2.7 (dd, 1H, J = 18.5, 7.9 
Hz) and 3.1 ppm (d, 1H, J = 18.5 Hz) and a doublet methyl at 






The skeletal structure of voeltzkowinols B, C and 0 
served as a template for constructing voeltzkowinol A. The 
diene system was replaced with partial structure 127. Since 
only one of the allylic methylene protons (62.7 ppm) showed 
coupling to the adjacent methine protons, 127 must exist in 
a very rigid ring. The absence of a carbonyl supported the 
formation of a 6-membered cyclic ether. The appearance of a 
carbon doublet at 156 ppm and the disappearance of one of 
the primary alcohol carbon signals (~60 ppm) defined the 
location of the third ring. A strong fragment ion at m/z 
163 (M+ - CH2-0H) secured the presence of the furan ring and 
negated the possibility of a pyran ring present in 
voeltzkowinol A. 
A chemically plausible biogenesis of voeltzkowinol A 
from voeltzkowinol 0 was proposed (Figure 21). Compound 128 
represents the hemi-acetal form of voeltzkowinol D. A 4 + 2 
intramolecular cyclization results in the formation of 
intermediate 129. Hydride attack at the olefinic carbon 
followed by the ensuing flow of electrons and the expulsion 
of a hydroxyl group would produce voeltzkowinol A. 
The voeltzkowinols exhibited varying degrees of 
cytotoxicity when tested irr vitro against the L1210 murine 
1 e u k e m i ace 11 1 i n e (A, 3. 4 11g I m 1; B, 5. 6 11g I m 1; C, 5. 6 
11g/ml; D, 0.56 11g/ml). This activity may be attributed to 
their ability to serve as Michael acceptors. 







Figure 21. Proposed biogenesis of voeltzkowinol A 
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prostaglandins, a family of organic acids containing a five 
membered ring and derived from essential fatty acids via 
arachidonic acid. Prostaglandins exhibit different effects 
on several major bodily functions {i .e., nervous system, 
reproductive system, inflammation-gastrointestinal tract).90 
There have been several reports of eicosanoids isolated from 
marine sources 88 ,91-94 many of which possess significant 
biological activity. One of the punaglandins (130)91 
exhibited an IC50 value of 0.02 ~g/ml (L1210 assay). The 
clavulones showed antiinflammatory effects at 30 ~g/ml in 
the fertile egg test and were reported to possess remarkable 
anticancer activity.95 The clavulones and the punaglandins 
all contain extended conjugated systems. This structural 
feature is present only in voeltzkowinol 0 and may explain 
the enhanced cytotoxicity of voeltzkowinol 0 over Band C. 
The major metabolite isolated from Didemnum voeltzkowi 
was tributyl tin chloride (131). It was isolated as a pure 
compound or complexed in differing percentages with each of 
the four voeltzkowinols. Signals in the IH [01.66 (m, IH), 
1.35 (m, 2H), 1.20 (t, 2H, J = 8.6 Hz) , 0.93 (t, 3H, J = 
7.5 Hz)] and 13C NMR spectrum [27.8 (t), 26.8 (t), 17.5 (t), 
13.6(q)] indicated the presence of a butyl group. The major 
peaks in the E1 mass spectrum were m/z 326(M+), 291, 269(B), 
234, 213, 177, 155, 121, 57. A daughter plot established 
that all these peaks were derived from the same molecule. 







peak (269) is 57 amu's confirming that the structure was a 
butyl derivative. Another frequent loss was 35 amu's 
indicating the presence of chlorine. The molecular ion 
appeared as an intricate isotope pattern that was unlike any 
of the common chlorine clusters that one normally 
encounters. Based on the ability of tunicates to sequester 
transition metals from sea water, metal ions with isotope 
ratios that could produce the observed isotope pattern were 
sought. Tin was a logical candidate because of its many 
isotopes (116S n-124S n). Computer-derived isotope 
distribution ratios for m/z 326 (C12H27SnCl) and m/z 269 
(CSHISSnCl) matched erfectly with the observed isotope 
distribution in the real spectrum supporting our assignment. 
The structure of tributyl tin chloride was subsequently 
confirmed by comparison with an authentic sample. 
The source of tributyl tin chloride in the extract is 
unknown. It is unlikely that tributyl tin chloride is a 
natural product. Contamination of the sample during the 
isolation procedure is also unlikely because the tunicate 
was frozen immediately at the collection site in Fiji and no 
bottles of tributyl tin chloride were found in Dr. Ireland's 
lab. Interestingly, tributyl tin chloride is an additive in 
marine paints and also in the coatings on underwater cables. 
Tunicates have the ability to sequester metals from sea 
water and Didemnum voeltzkowi was collected on a coral reef 
approximately 50 yards from a drilling site. 
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The Chemistry of Lissoclinum patella* 
Lissoclinum patella is a compound tunicate with an 
easily recognizable body. Colonies of l. patella have been 
collected in the Western Caroline Islands by snorkeling 
(-2m) and during a recent expedition off the coast of Suva, 
Fiji by SCUBA (-3m). Like many didemnid tunicates, l. 
patella harbors symbiotic algae as evidenced by the green 
hue showing through the translucent mantle. 
The initial investigation of Lissoclinum patella 
yielded eight cyclic peptides characterized by the presence 
of oxazoline and thiazole amino aCids. 54 - 56 My contribution 
to the investigation of Lissoclinum patella has focused on 
the structure revision of the patellamides using the COSY 45 
technique. In addition to evaluating the patellamide 
structures, three new cyclic peptides were isolated from l. 
patella. 59 Interestingly, their structures were remarkably 
similar to three known lissoclinum peptides. The new 
metabolites all contain a thiazole amino acid. In place of 
the oxazoline ring, however, is its threonine precursor. 
Germane to this discussion is a brief overview of the 
events leading to the structure revision of the 
patellamides. Ulicyclamide 132 and ulithiacyclamide ~ were 
the first two cyclic peptides isolated from l. patella. 54 
Their amino acid composition was determined based on 
*Tables of IH and 13C NMR data for the lissoclinum peptides 






spectral analysis of the intact peptide and comparison of 
the acid hydrolysis products with authentic material. Their 
amino acid sequence was established from ElMS fragmentation 
patterns. Of equal importance was the multiplicity of the 
alpha amino proton (H-2) of the 82,3 oxazoline ring which 
served as an indicator for the type of substituent at C-4. 
Weinberger reported homoallylic (five bond) coupling (1.5 
Hz) in 2-methyl-8 2-oxazoline between the proton at C-4 and 
the methyl protons. 96 The alpha amino proton (H-2) of 
ulicyclamide (132) appeared as a simple doublet (J = 4 Hz) 
suggesting that there were no protons on the carbon attached 
to C-4 and confirming placement of the thiazole at that 
position. In ulithiacyclamide (~) the alpha amino proton 
of the oxazoline ring appeared as a doublet of doublets with 
coupling constants of 8 and 2 Hz. The 2 Hz coupling 
constant represented homoallylic coupling through the 
oxazoline ring between H-2 and the proton on the carbon 
attached at C-6. Subsequent decoupling studies revealed 
that irradiation of the a-cysteinyl proton at 5.3 ppm 
resulted in a sharpening of the a-oxazoline proton (4.25 
ppm) indicating that the substituent at C-6 was cysteine. 
In 1982 Ireland and co-workers reported the structures 
of patellamides A, Band C (56-58), all of which contained 
fused oxazoline-thiazole ring systems. 55 EI mass spectral 
analysis of the tripeptide obtained by selective hydrolysis 
of the cyclic peptide was consistent for two sets of 
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structures ~-~ and ~-~. The alpha amino protons of the 
oxazoline rings appeared as sharp doublets (lH: 4.30, d, J = 
4 Hz) reminiscent of the oxazoline proton in ulicyclamide 
(lH: 4.26, d, J = 4 Hz). Irradiation studies failed to show 
homoallylic coupling to the oxazoline protons via a 
sharpening of their signals. Therefore structures (~-~) 
containing fused oxazoline-thiazole ring systems were chosen 
based on the absence of homoallylic coupling. 
In 1983 Ireland reported the structures of 
Lissoclinamide 1,2 and 3 (~_Ql).56 Note that the 
structures contain no fused oxazoline-thiazoles even though, 
in the IH NMR spectrum, the alpha amino protons of the 
oxazoline ring appear as doublets (lH: 4.30, d, J = 4 Hz). 
The amino acid sequences were secured by interpretation of 
FAB mass spectral data of a selective hydrolysis product. 
Interestingly, the amino acid composition of lissoclinamide 
2 (~) and 3 (Ql) was identical to ulicyclamide (132). The 
lack of homoallylic coupling in the lissoclinamides and the 
availability of FABMS (which is a softer and oftentimes more 
informative mode of ionization) prompted a reevaluation of 
the structural assignment of ulicyclamide. After 
examination of the selective hydrolysis product from 
ulicyclamide by HRFABMS, ulicyclamide was reassigned 
structure ~.56 The new structure did not contain a fused 
oxazoline-thiazole ring system. Conventional decoupling 
studies had failed to detect homoallylic coupling because 
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the coupling was too small (J < 0.5Hz). Since the same 
criterion was used to assign the structures of patellamides 
A, Band C (in particular the fused oxazoline-thiazole sub 
structure), it was decided that a reinvestigation of the 
patellamides was necessary. In the case of the patellamides 
FABMS data did not distinguish between the two sets of 
possible structures. Therefore, a method was needed that 
could detect small couplings (J < 0.5 Hz) between alpha 
amino protons. Two dimensional homonuclear correlation 
experiments held the distinction of detecting long range 
couplings that were difficult or impossible to detect by 
conventional 10 methods. 97 ,98 Coincidental with the renewed 
interest in the patellamides was the arrival of the IBM 200 
MHz NMR equipped with 20 software. Several different 
homonuclear correlation experiments were tried using 
ulicyclamide as a model compound: COSY 90, COSY 45, long 
range COSY and phase sensitive COSY. After comparative 
analysis of the contour maps obtained from each experiment 
the COSY 45 pulse sequence was chosen. It provided more 
long range coupling information in addition to suppressing 
diagonal distortions. A SECSY experiment was also run on 
ulicyclamide. Although comparable to the COSY 45 experiment 
in detecting homoallylic coupling, the data as presented led 
to ambiguous assignments. 
Before revealing the results of the NMR study a brief 
discussion of the basic theory behind a 20 NMR experiment 
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will be presented. 99 The combination of fourier 
transformation and programmable pulse transmitters was 
directly responsible for the development of the 20 NMR 
experiment. The breakdown of a typical NMR experiment into 
its three time periods is shown in Figure 22 (top). The 
preparation time simply prepares the spins for evolution. 
Ouring the evolution period the spins are allowed to evolve 
or dephase with their coupling constants, chemical shift or 
both. At the end of the evolution period, the signal is 
detected and an FlO recorded. In a 10 NMR experiment tl is 
fixed. In a 20 NMR experiment t1 varies. 
A simplified representation of 20 NMR spectroscopy is 
shown in Figure 22 (bottom). The left diagram represents 
amplitude modulation, the right diagram represents phase 
modulation. However, the explanation is the same in both 
cases. Each row represents a 10 NMR spectrum. The signal 
intensity is different in each spectrum because it depends 
on how long the spin systems have been allowed to evolve. 
Since tl' the evolution time, varies so does the signal 
intensity. A sine wave is formed by connecting the apex of 
each peak. A fourier transformation of this new sine wave 
results in the formation of an NMR spectrum in the 2nd 
dimension. Simply put, 20 NMR is a fourier transformation 
of a series of fourier transformations. 
The pulse train for a COSY 45 experiment along with its 
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Figure 23. Pulse train and vector analysis for the COSY 45 experiment 
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all the spins are aligned with the field along the Z-axis. 
The first 90 0 pulse flips all the spins along the x-y plane 
thereby creating transverse magnetization. The spins are 
allowed to evolve for a time tl before the second 45 0 pulse 
is applied. This pulse serves as a mixing pulse and results 
in the exchange of magnetization between coupled nuclei. An 
FID is collected, tl is incremented a predetermined amount 
and the entire pulse sequence is repeated. At the end of 
the experiment a computer performs the necessary FT 
calculations and the data are presented as a contour map. 
The first compound to be tested was ulicyclamide. A 
32W by 1K data matrix was generated in thirty minutes. A 
portion of the COSY 45 spectrum is shown in Figure 24. As 
mentioned earlier, the diagonal represents the 1D spectrum. 
Symmetrical crosspeaks above and below the diagonal connect 
* protons that are coupled. Present in the COSY 45 spectrum 
of ulicyclamide are crosspeaks connecting the a-oxazoline 
proton (H-2) and the a -Ile proton {H-27}. Interestingly, 
this connection represents homoallylic coupling through the 
amide linkage rather than through the oxazoline ring. This 
proved to be a very informative observation because it 
provided an additional handle for establishing the correct 
amino acid sequence of the cyclic peptides. There is 
precedence in the literature for the observation of 
*A table of 5JH_H connectivities for the lissoclinum 
peptides can be found in the appendix. 
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Figure 24. COSY 45 spectrum of ulicyclamide 
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homoallylic coupling through an amide bond. Barfield 
reported the presence of 5JH_H using spin tickling on model 
compounds 133-135 100 and Kessler detected similar couplings 
in cyclo-(L-Pro-L-Pro-O-Pro) (136) using the sophisticated 
20 spin-echo homonuclear correlated (SECSY) experiment. 101 
A logical explanation for the detection of homoallylic 
coupling through the amide linkage could be the imino 
character associated with the amide bond. Unfortunately, 
crosspeaks connecting H-2 and the a-Pro proton (H-27) 
through the oxazoline ring were missing. The absence of 
coupling in this case probably reflects a 90° orientation 
between H-2 and H-27. 
The next compound to be tested was patellamide B. The 
COSY 45 spectrum is shown in Figure 25 along with its 10 1H 
NMR spectrum. The key features in the 10 NMR spectrum are 
the two sharp doublets for the two a-oxazoline protons [(H-
2, 4.38, d, J = 4 Hz), (H-22, 4.29, d, J = 4 Hz)] the 
signals for the a-Ile (H-26, 4.77 dd, J = 11, 7 Hz), a-Leu 
(H-6, 5.01, m), and the a-Ala and a-Phe thiazole protons 
[(H-35, 5.39, dq, J = 9, 7 Hz), (H-15, 5.50, ddd, J = 10, 
10, 7 Hz)] respectively. Present are four crosspeaks of 
varying intensity between 4.7 and 5.7 ppm. These crosspeaks 
represent connectivities via homoallylic coupling between H-
2 <--> H-6 and H-22 <--> H-26 through the oxazoline ring and 
H-2 <--> H-35 and H-22 <--> H-15 through the amide linkage. 
These new pieces of data supported revised structure ~ for 
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Figure 25. COSY 45 spectu~ of patellamide B 
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patellamide B. The revised structure was also supported by 
FAB MS/MS daughter ion analysis of a tripeptide obtained by 
selective hydrolysis of patellamide B (Figure 26). The 
tandem MS measurements were recorded on a VG ZAB 4F 
instrument. An in-depth analysis of the resulting mass 
spectrum was provided by Dr. Simon Gaskell. The sequence on 
the left is the interpretation based on the tripeptide 
derived from the revised structure. The sequence on the 
right is the interpretation based on the tripeptide derived 
from the original structure. The analysis is the same until 
assignments are made for the ions at m/z 138 and 155. The 
generation of these ions from the 223 ion is plausible only 
in sequence A and the revised structure vida infra. It 
should be noted that it is possible to generate ions with 
m/z 138 and 155 from fragment structures in column B. 
However, it is not possible to generate these ions (m/z 138, 
155) from the 223 ion. Therefore, conventional FAB MS data 
does not distinguish between the two possible structures for 
the patellamides. 
The COSY 45 spectrum of patellamide A was supportive of 
revised structure~. A sample of patellamide C was not 
available. However, due to its spectral similarities with 
patellamide B it was reassigned structure~. Concurrent 
with this work, Professor Shioiri confirmed the revised 








Figure 26. MS/MS analysis of a tripeptide obtained 
from patellamide B 
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The detection of five-bond coupling is not unique to 
the patellamides. Present in the COSY 45 contour map of 
lissoclinamide 2 are crosspeaks connecting the a-oxazoline 
proton (H-2, 4.27, d, J = 5 Hz) to the a-Pro proton (H-6, 
4.59, t, J = 8 Hz) through the oxazoline ring and also H-2 
to the a-Ile proton (H-27, 4.81, m) through the amide 
linkage. 
Samples of the lissoclinum peptides used in the COSY 45 
experiments were obtained by RP-HPLC of extracts from two 
previous workups of l. patella (Whatman 00S-2; 80:20, 
MeOH:H20). The HPLC chromatography also provided three new 
peptides: prelissoclinamide-2 (~, 33mg, 0.5% of extract), 
prepatellamide-B-formate (~, 13 mg, 0.2%) and 
preulicyclamide (~, 13 mg., 0.2%). 
The first minor metabolite was named prelissoclinamide-
2 ~ because it had the same amino acid sequence and 
stereochemistry as lissoclinamide-2 60 but the oxazoline was 
now opened. It was assigned a molecular formula 
C33H43N706S2 by HRFABMS measurements (obs. 698.2828; MH+ 
requires 698.2793) suggesting that it differed from the 
lissoclinamides (MW 679) by the addition of water. IR 
stretches at 1680 and 1660 cm- 1 and five carbon resonances 
between 170 and 180 ppm indicated a penta-peptide system. 
Interpretation of the 1H and 13NMR data of the new peptide 
confirmed the presence of an Ala-thiazole [ 1H 07.95 (s), 






0148.2, 123.5, 159.6, 47.4, 22.1 ] Ile-thiazoline [ 1H 05.25 
(m, 1 H ) , 3.59 (m, 2H), 5.33 (dd, 1H, J = 8.5, 8 Hz), 2.58 
(m, 1 H , ) , 1 .40 (m, 2H), 0.97 ( t , 3H, J 7.3 Hz), 1 . 1 2 (d , 
3H, J = 7 Hz) ; 13C 079.8, 35.4, 171.0, 55.0, 37.9, 26.6, 
1 2 .0, 14.7 ] , Phe [ 1H 05.18 (ddd, 1 H , J = 9, 7 , 7 Hz), 
3.15, (dd, 1H, J = 14, 7 Hz), 3.09 (dd, 1H, J = 14, 7 Hz), 
7.36 (m, 5H); 13C 052.4,40.7,136.1,128.9 (2C), 129.3 
(2C), 127.4] and Pro [ 1H 04.30 (t, 1H, J = 8 Hz), 1.84, 
(m, 1H), 2.39 (m, 1H), 1.84 (m, 1H), 3.59 (m, 1H), 2.58 (m, 
1H); 13C 063.2, 29.8, 25.3, 47.8]. The remaining spin 
systems in the 1H NMR [06.45 (d, 1H, J = 8.7 Hz), 4.43 (d, 
1H, J = 8.7 Hz), 4.84 (q, 1H, J = 6.5 Hz) and 1.29 (d, 3H, J 
= 6.5 Hz ] defined an open Thr unit. The a- and B-protons 
of the Thr unit failed to show coupling indicating that they 
exist in a fixed conformation with the angle between the two 
protons approaching 90°.102 Complete assignment of the NMR 
signals was based on conventional decoupling experiments, 
heteronuclear correlation experiments that indicated C-H 
connectivities and the COSY 45 experiment that not only 
confirmed the results of the conventional decoupling study 
but was very useful in establishing the amino acid sequence. 
Crosspeaks were present connecting the a-Ile thiazoline 
proton (H-27) to the a-Thr proton (H-2) which showed 
connections to the a-Pro proton (H-6) which showed an 
additional connection to the a-Phe proton (H-11) 
establishing the sequence Ile thiazoline-Thr-Pro-Phe present 
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in the molecule. 
The structure and stereochemistry of prelissoclinamide-
2 was confirmed by the reaction sequence shown in Figure 27. 
Lissoclinamide-2 (~) was refluxed in 5% H2S04/MeOH forming 
the amino lactone intermediate 127 which then underwent 
transacylation in strong base yielding prelissoclinamide-2. 
The spectral data and optical rotation of the degradation 
product and the natural product were found to be identical. 
The second minor metabolite was named prepatellamide-
B-formate (~) based on its compositional similarity to 
patellamide B. It was assigned a molecular formula 
C39H50N808S2 by HRFABMS (obs. 823.3254, MH+ requires 
823.3271). Comparison of the spectral data of 
prepatellamide-B-formate with patellamide B indicated the 
presence of Ala and Phe thiazoles, Leu, Ile but only one 
oxazoline [IH NMR: 84.27 (d, J = 2.6 Hz), 4.95 (dq, IH, J = 
5.3,2.6 Hz), 1.41 (q, 3H, J = 5.3 Hz)]. The major changes 
in the IH NMR spectrum, Figure 28, are 1) a new amide NH 
proton at 7.04 ppm (d, J = 9Hz), 2) a downfield shift of 
what was one of the oxazol i ne protons (<5 4.29 in the 
patellamide B spectrum) to 4.76 ppm (d, J = Hz), 3) a 
methinyl quartet at 5.76 ppm (q, J = 6.6 Hz) and 4) a 
doublet methyl at 1.43 ppm (d, J = 6.6 Hz) all of which 
defines a threonine unit and 5) a singlet at 8.5 ppm that 
correlates via a HETCOR experiment to a carbon signal at 161 














































preferential ring opening of one of the oxazoline rings was 
obtained from the COSY 45 spectrum (Figure 29). The 
oxazoline proton (H-2) shows a connectivity to the a-Ala-
thiazole proton (H-36) and to the a-Ile proton (H-6). No 
coupling was observed between the a- and S-protons of the 
Thr unit indicating that it too exists in a fixed 
conformation. 
The third minor metabolite was named preulicyclamide 
(Q!) and assigned a molecular formula C33H41N706S2 by high 
resolution FAB mass measurement (obs. 696.2652, MH+ requires 
696.2622). Initial inspection of the 1H and 13C NMR data 
revealed the presence of Ala and Ile thiazoles, Phe, Pro and 
again an oxazoline replaced by a Thr unit [lH 06.99 (d, NH, 
J = 6.6 Hz), 4.03 (dd, 1H, J = 7.4, 6.6 Hz), 4.70 (dq, 1H, J 
= 7.4, 6.6 Hz), 1.19 (d, 3H, J = 6.6 Hz)]. The 7.4 Hz 
coupling constant represents 3JH_H between the a-and S-
protons of threonine indicating that in preulicyclamide the 
Thr exists as a freely rotating unit. The COSY 45 spectrum 
established the sequence Ile thiazole-Thr-Pro-Phe confirming 
the proposed structure. 
Harsh conditions are necessary to effect ring opening 
of the oxazoline ring. Therefore, it ;s proposed that the 
three new lissoclinum peptides are not artefacts of the 
work-up procedure. Rather, they are postulated precursors 
in the biosynthetic pathway leading to formation of the 
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Figure 29. COSY 45 spectrum of prepatellamide-B-formate 
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formation of the oxazoline ring. 
The lissoclinum peptides were tested irr vitro against 
the L1210 murine leukemia cell line. The results, shown in 
Table 2, are very perplexing. Prelissoclinamide-2 exhibited 
good biological activity (ICSO 2.7 pg/ml) whereas 
lissoclinamide 2 was completely inactive (ICSO >10 pg/ml). 
These results indicate that the threonine unit may be 
responsible for the biological activity. If this were true 
then prepatellamide-B-formate and preulicyclamide should be 
more active then patellamide B or ulicyclamide respectively. 
However, the exact opposite is observed. In fact, 
prepatellamide-B-formate and preulicyclamide were completely 
inactive. Therefore, the threonine unit is probably not 
responsible for the activity and the explanation for the 
observed activities or lack thereof remains a mystery. 
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Table 2 
L1210 values for the lissoelinum peptides 
Compound 
ul i eyel ami de 7.2 
ulithiaeyelamide 0.35 
patellamide A 3.9 
patellamide B 2.0 
patellamide C 3.2 
lissoelinamide 1 >10 
lissoelinamide 2 >10 
lissoelinamide 3 >10 
prelissoelinamide 2 2.7 




Infrared spectra were recorded on a Beckman 620 MX 
spectrophotometer. UV spectra were recorded on a Beckman 
DU-8 spectrophotometer. 1H and 13C NMR spectra were 
recorded on a Bruker WM 500 spectrometer at Yale University, 
a JEOL 270 or an IBM 200 spectrometer. All 2D NMR spectra 
were recorded on the IBM 200 MHz spectrometer equipped with 
an Aspect 3000 computer. Chemical shifts are reported in 
ppms downfield from Me4Si (6=0) for proton spectra or using 
the central line of the 2HCC13 triplet (77.0 ppm) as the 
internal reference for 13C measurements. Electron 
ionization mass spectra were recorded on an AEI MS-902 
(University of Connecticut) or on a Varian MAT 112S 
spectrometer. Low resolution CI and FAB mass spectra were 
also recorded on the Varian MAT 112S spectrometer. High 
resolution FAB/MS measurements were made using a Varian MAT 
731 spectrometer. Tandem MS/MS measurements were recorded 
on a VG ZAB 4F instrument. Optical rotations were recorded 
on a Perkin-Elmer 241MC polarimeter. HPLC separations 
(analytical and preparatory) were performed on a Waters 
system equipped with a U6K injector, a 501 pump and an R401 
differential refractometer. Melting points were measured on 
a Thomas capillary melting point apparatus. 
125 
L12l0 assays were performed at the University of 
Vermont under the direction of Dr. Miles Hacker. The L12l0 
murine leukemia cells were grown as a stationary suspension 
cultured in vitro in McCoyts SA medium supplemented with 10% 
newborn calf serum t penicillin (100 ~g/ml), streptomycin 
(100 ~g/ml) and fungizone (0.25 ~g/ml). Cultures were 
maintained at 37° in a humidified atmosphere of 90% air/lO% 
C02. LI2l0 cells grown under these conditions have a 
doubling time of approximately ISh. 
Compounds were dissolved in sterile DMSO at 
concentrations such that a 40 ~l addition of the solution to 
4 ml of cell suspension delivered the desired final 
concentration of test compound. RoutinelYt 4 ml of L12l0 
cells (105 ce ll s/ ml) were added to 15 ml of disposable tissue 
culture tubes. The test compound was then added to the 
cells, and the cultures were incubated for 96h. Cell 
concentration was measured electronically by using a Coulter 
particle counter (Model ZBF)' 
Baseline separation was achieved in the HPLC 
purification of the voeltzkowinols and the lissoclinum 
peptides. This insured 95% purity for each metabolite. The 
IH NMR spectrum of all the metabolites also established 
their purity. 
The Chemistry of an Unidentified Tunicate 
Collection, extraction and chromatography. The 
encrusting tunicate was collected on exposed rocks at the 
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northwest end of Cocos lagoon, Guam. It was placed in a 
freezer bag and kept frozen until work-up. The tunicate was 
freeze-dried (116g, dry weight) and extracted in a Soxhlet 
extraction apparatus with petroleum ether, CC14 and then 
CHC13' The freeze-dried material was then placed in 500 ml 
of MeOH and extracted overnight. On standing, a precipitate 
began to appear in the CHC13 extract. It was subsequently 
identified as 3,5-diiodo-4-methoxyphenethylamine (!i) (453 
mg, 0.39% dry weight). The CHC13 extract was refrigerated 
and a second compound, identified as the urea analog (~) 
(20 mg, 0.017% dry weight) precipitated from solution. Each 
precipitate was collected by vacuum filtration. The solvent 
from each extract was removed in vacuo and the resulting oil 
was dissolved in CHC13 or MeOH and refrigerated. A Img 
sample from each extract was sent to the University of 
Vermont for cytotoxic evaluation in the L1210 assay. 
3,5-diiodo-4-methoxyphenethylamine (45). mp obs 
209-212°C, lit 213°C; UV 265nm (£ 2200); lR (KBr) 3650-3200, 
3000, 2920, 1000, 860, 710 cm- 1; 1H NMR (DMSO) 88.26 (s, 
2H), 7.76 (s, 2H), 3.73 (s, 3H), 3.03 (t, 2H, J = 8 Hz), 
2.86 (t, 2H, J = 7 Hz); 13C NMR (DMSO) 0157.1 (s), 139.7 
(d), 139.66 (d), 137.7 (s), 91.5 (2C, s), 60.1 (q), 39.4 
(t), 30.8 (t); HRElMS mlz 402.8941, C9HIINOI2 requires 
402.8929; ElMS mlz 403 (M+), 386, 374 (B), 359. 
Bis 3,5-diiodo-4-methoxyphenethylurea (46). mp 224-225 
°C; 1H NMR (DMSO) 87.56 (s, 2H), 5.78 (t, 1H, J = 6 Hz), 
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3.62 (s, 3H), 3.08 (dt, 2H, J = 7, 6 Hz), 2.49 (t, 2H, J = 7 
Hz); 13C NMR (DMSO) 8157.8 (s), 156.6 (s), 140.2 (d), 139.6 
(d), 91.0 (s), 60.1 (q), 40.4, (t), 34.1 (t); HREIMS mlz 
831.7699, C19H20N203I4 requires 831.7675; ElMS mlz 832 (M+), 
705, 429, 403, 373 (8). 
Formation of N-acety1tyramine (106). In a 50 m1 3-
necked rbf was suspended tyramine (Aldrich, 200 mg) in 10 m1 
distilled H20. The contents of the flask were heated to 90-
95°C at which temperature 1100 ~1 acetic anhydride was 
added in 8 portions (137 ~1 each) over a 3 minute period. 
The reaction was monitored by TLC (Silica gel, EtOAc). 
After 3 hours heating was discontinued and the volatiles 
were removed in vacuo. The product was purified using 
vacuum filtration through silica (silica gel, EtOAC). The 
overall yield was 97%. 
N-Acety1tyramine (106). IR (CHC13) 1625 cm- 1; 1H NMR 
(60 MHz, DMSO) 87.4 (br s, 2H), 6.5 (dd, 2H), 2.9 (m, 2H), 
2.4 (m, 2H), 1.6 (s, 3H). 
Formation of 3,5-diiodo-N-acety1 tyramine (107). To 
a 50 m1 rbf containing a solution of N-acetY1 tyramine (80 
mg; 0.45mM) dissolved in gl acetic acid (1.5m1) was added 
with stirring, IC1 (75 ~1; 1.44 mM). The reaction was 
heated to 80°C and allowed to react for 17 hours. The 
solvent was removed in vacuo and the product was purified 
using vacuum filtration (3/4" bed of silica gel 60 eluted 
with EtOAc). The overall yield was 37%. 
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3,5-diiodo-N-acetyl tyramine (107). 1H NMR (60 MHz, 
d6-acetone) 07.1 (s, 2H) 2.84 (m, 2H), 2.16 (m, 2H), 1.28 
(s, 3H); ElMS m/z 431 (M+), 372, 359, 30S, 246, 233; HRElMS 
m/z 430.8880, C10H11N02l2 requires 430.8890. 
Formation of 3,S-diiodo-4-methoxY-N-acetyl tyramine 
(108). To a SO ml rbf containing 3,S-diiodo-N-acetyl 
tyramine (45 mg; 0.104 mM) in EtOAc (5 ml) was added with 
stirring, NaH (6 mg; 0.12S mM) and dimethyl sulfate (lS1Jl; 
20 mg; 0.158 mM). The reaction was held at reflux for IS 
hrs. At the end of the reaction time, the solvent was 
removed in vacuo and the residue concentrated on the vacuum 
pump for 10 min. The contents of the flask were then 
dissolved in MeOH. Analysis of this solution by TLC (silica 
gel, EtOAc) showed one spot that was less polar than the 
starting material. The yield of this reaction was 67%. 
3,5-diiodo-4-methoxy-N-acetyltyramine (108). 1H NMR 
(60 MHz, CDC13) 07.S (s, 2H), 3.8 (s, 3H), 3.3 (m, 2H), 2.7 
(m, 2H), 1.9 (s, 3H). 
Formation of 3,S-diiodo-4-methoxvphenethylamine (45). 
Approximately 28 mg of 3,S-diiodo-4-methoxy-N-acetyltyramine 
was transferred to a threaded test tube in MeOH. The 
solvent was removed under N2 and five ml of 6N HCl was added 
to the residue. The reaction vessel was capped and placed 
in a 110°C oven and left overnight. After 12 hours the tube 
was removed from the oven and allowed to cool to room 
temperature before the solvent was removed in vacuo. The 
residue was dissolved in DMSO for IH NMR analysis and 
structural conformation. The yield was 80%. 
The Chemistry of Didemnum voe1tzkowi 
Collection, isolation and chromatography. Didemnum 
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voe1tzkowi was collected at low tide on a coral reef 
approximately one mile off the coast of Suva, Fiji. The 
freeze-dried tunicate (625 g, dry weight) was homogenized 
with 1.25 L of MeOH. The homogenate was divided into three 
equal portions, transferred to erlenmeyer flasks and allowed 
to extract in the refrigerator overnight. The solvent was 
removed in vacuo leaving a dark green oil that contained 
several UV-active compounds. The oil was dissolved in MeOH 
(100 ml) and partitioned with CHC13 (3 x 125ml). 
Examination of the CHC13 and MeOH fractions by TLC (silica 
gel, EtOAc) indicated that the voeltzkowinols were present 
in the MeOH fraction. The contents of the MeOH fraction 
(3.9 g) were partitioned between BuOH/H20. The butanol 
fraction was chromatographed on a 6 ft. Sephadex column (LH-
20, CHC13:MeOH, 1:1). The voeltzkowinols eluted together in 
a light yellow band immediately following a dark green 
pigment-containing band. The appropriate fractions were 
combined and concentrated to a light yellow oil (756 mg). 
The oil was further purified by HPLC (~ partisil M9 10/50, 
EtOAc:TMP, 8:2) yielding voe1tzkowinol A (96, 4 mg, 0.002% 
dry weight), B (~, 22 mg, 0.007% dry weight), C(98, 13 mg, 
0.006% dry weight) and D (~, 47 mg, 0.02% dry weight). 
Voeltzkowinols A-D are easily identified by their 
characteristic Rf values of 0.4, 0.2, 0.15 and 0.08 
respectively. 
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Voeltzkowinol A (96). [a]D +43.4°; IR (CHC13) 3620 cm- 1 
UV (MeOH) 354 (E: 6500), 270 (E: 20000), 231 nm (E: 22000); 1H 
NMR( CDC1 3) 01.42 (d, 3H, J = 5.9 Hz), 2.70 (dd, 1H, J=18.5, 
7.9 Hz), 3.05 (d, 1H, J 18.5 Hz), 4.32 (m, 1H, J = 7.9, 
5.9 Hz), 4.67 (d, 1H, J = 15 Hz), 4.92 (d, 1H, J = 15 Hz), 
5.89 (d, 1H, J = 6 Hz), 6.93 (s, 1H), 7.71 (d, 1H, J = 6 
Hz); 13C NMR (CDC13) 022.0 (q), 41.5 (t), 60.8 (t), 78.6 
(d), 117.9 (s), 127.3 (d), 128.8 (s), 147.9 (d) 152.1 (s) 
155.9 (d); HREIMS mlz 192.0786, C11H1203 requires 192.0783. 
Voeltzkowinol B (97). [a]D -25.3°; IR (MeOH) 3600-3200, 
1704 cm- 1; UV (MeOH) 231 nm (E: 1600); 1H NMR(d4-MeOH) 03.59 
(d , 1 H , J = 10.5 Hz), 3.69 ( d , 1 H , J = 10.5 Hz), 3.88 ( s , 
1 H) , 3.96 (d, 1 H , J = 12.6 Hz) , 4.24 (d , 1 H , J = 12.6 Hz) . 
5.21 ( d , 1 H , J = 10.6 Hz), 5.31 (d , 1 H , J = 16.5 Hz), 6.25 
(d, 1H, J = 6 Hz), 6.38 (d, 1 H , J = 11 . 2 Hz), 6.65 (ddd, 1 H , 
J=16.5, 11.2, 10.6 Hz), 7.51 (d, 1H, J = 6 Hz); 13C NMR(d4-
MeOH) 653.0 (d), 65.3 (t), 66.6 (t), 82.2 (s), 119.8 (t), 
133.5 (d), 133.7 (d), 135.0 (d), 136.1 (s), 166.4 (d), 210.0 
(s); HREIMS mlz 210.0893, C11H1404 requires 210.0888. 
Voeltzkowinol C (98). [a]D -12.6°; IR (CHC13) 3600-3200 
1708 cm- 1; UV (MeOH) 231 nm (E: 20000); 1H NMR(d4-MeOH) 07.58 
(d, 1H, J = 6 Hz), 6.41 (m, 1H, J = 16.4, 16, 10 Hz), 6.26 
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1H, J = 16 Hz), 6.15 (d, 1H, J = 6 Hz), 5.27 (d, 1H, J = 
16.4 Hz), 5.16 (d, 1H, J = 10 Hz), 4.20 (d, 1H, J = 13.8 
Hz), 4.05 (d, 1H, J = 13.8 Hz), 3.31 (s, 3H); 13C NMR (d4-
MeOH) 0208.6 (s), 165.7 (d), 136.7 (s), 134.5 (d), 134.3 
(d), 132.6 (d), 119.5 (t), 83.7 (s), 65.8 (t), 65.3 (t), 
58.7 (d); HREIMS mlz 210.0900, C11H1404 requires 210.0888. 
Voeltzkowinol 0 (99). [a]o -16.4°; IR (MeOH) 3600-3000, 
1690 cm- 1; UV (MeOH) 307 (£ 10000), 233 nm ( £ 11000); 1H NMR 
(d4-MeOH) 0 1.90 (dd, 3H, J = 7, 1.3 Hz), 3.69 (d, 1H, J = 12 
Hz), 3.90 (d, 1H, J = 12 Hz), 4.57 (d, 1H, J = 11.8 Hz), 
4.83 (d, 1H, J = 11.8 Hz), 6.29 (d, 1H, J = 6 Hz), 6.52 (dq, 
IH, J = 16, 7 Hz), 7.40 (d, 1H, J = 6 Hz), 7.83 (dd, 1H, 
J=16, 1.3 Hz); 13C NMR (d4-MeOH) 019.4 (q), 58.3 (t), 68.2 
(t), 82.0 (s), 128.4 (d), 134.2 (s), 136.5 (d), 136.6 (d), 
146.8 (s), 161.5 (d), 199.1 (s); HREIMS mlz 210.0893, 
C11H1404 requires 210.0888. 
Acetylation of the voeltzkowinols. To 3 mg of a 
voeltzkowinol dissolved in 200 ~l of acetic anhydride was 
added 10 ~l of pyridine. The reaction was stirred at RT and 
monitored by TLC (silica, EtOAc). After 30 minutes of 
reaction time the mixture was evaporated under vacuum and 
the residue partitioned between CHC13 (20, ml) and water (20 
ml). The water layer was extracted 2X with CHC13 (20 ml 
each time). The combined CHC13 fractions were evaporated 
under vacuum and purified by HPLC (Partisil PXS 10/25, 
EtOAc:TMP, 1:1). 
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Voe1tzkowino1 A (126). (monoaeetate) IR (CHC13) 1735 
em-I; 1H NMR (COC13) 05.61 (d, 1H, J = 12.5 Hz), 5.27 (d, 
1H, J = 12.5 Hz), 2.10 (3, 3H). 
Voe1tzkowino1 B (109). (diaeetate) IR (CHC13) 3600-
3000, 1735 em-I; ElMS mlz 294; 1H NMR (COC13) 07.52 (d, 1H, 
J = 5.2 Hz) 6.47 (br s, 2H), 6.33 (d, 1H, J = 5.2 Hz), 5.41 
(d,lH,J=10.5Hz), 5.32 (d, 1H, J = 17.9 Hz), 4.65 (d, 1H, J = 
13.1 Hz), 4.53 (d,lH, J = 13.1 Hz), 4.53 (d, 1H, J = 13.1 
Hz), 4.34 (d, 1H, J = 11.2Hz) 4.18 (d, 1H, J = 11.2 Hz), 
3.70 (br s, 1HO, 2.09 (s, 3H), 2.04 (s, 3H); HREIMS mlz 
294.1090, C15H1806 requires 294.1116. 
Voe1tzkowino1 C (110). (diaeetate) IR (CHC13) 1741, 
1720 em-I; ElMS mlz 294; 1H NMR (COC13) 04.77 (d, 1H, J = 
13.8 Hz), 4.55 (d, 1H, J = 13.8 Hz), 4.16 (br s, 2H), 2.13 
(s, 3H), 2.02 (s, 3H); HREIMS mlz 294.1098, C15H1806 
requires 294.1116. 
Voe1tzkowino1 O. [diaeetate, (114)] IR (CHC13) 3600-
3200, 1735 em-I; ElMS mlz 294; 1H NMR (COC13) 07.72 (d, 1H, 
J = 15.9, 1.3 Hz), 7.32 (d, 1H, J = 6 Hz), 6.38 (m, J 
15.9, 7 Hz), 6.32 (d, 1H, J = 6 Hz), 5.47 (d, 1H, J 12.5 
Hz), 4.96 (d, 1H, J = 12.5Hz), 4.33 (d, 1H, J = 11.8 Hz), 
4.15 d, 1H, J = 11.8 Hz), 2.03 (s, 6H), 1.91 (dd, 3H, J = 7, 
1.3 Hz); HREIMS mlz 294.1098, C15H1806 requires 294.1116. 
[triaeetate, (115)] IR (CHC13) 1741 (br), 1686 em-I; ElMS 
mlz 336; 1H NMR (COC13) 07.83 (d, 1H, J = 15.8, 1.3 Hz), 
7.39 (d, 1H, J = 6 Hz), 6.42 (d, 1H, J = 6 Hz), 6.26 (dq, 
133 
IH, J = 15.8, 6.5 Hz) , 5.00 ( s , 3HO, 4.57 (d, 1 H , J = 1 1 . 2 
Hz) , 4.15 (d, 1 H , J = 11.2 Hz), 2.06 ( s , 3 H) , 2.04 ( s , 3H), 
2.02 (S, 3 H) , 1 .90 (dd, 3H, J = 6.5, 1 .3 Hz) ; HREIMS mlz 
336.1212, C17H2007 requires 336.1203. 
Mn02 oxidation of the voeltzkowinols. To 1 equivalent 
of a voeltzkowinol partially dissolved in CH2C12 (2 ml) was 
slowly added with stirring 36 equivalents of activated Mn02' 
The reaction was stirred at RT and monitored by TLC (silica 
gel, EtOAc). The reaction was complete in 50 minutes and 
the reaction mixture was filtered through a scintered glass 
funnel. The Mn02 was rinsed 3X with CH2C12' The filtrate 
was evaporated under vacuum and purified by HPLC (Partisil 
PXS 10/25, EtOAc:TMP, 7:3). 
Voeltzkowinol B. [(y-lactone, ( 111 1 ] IR ( CHC1 3) 3600-
3200, 1751, 1719 cm- 1; UV (MeOH) 268.9 (£ 6.2 xl0 5) ; IH NMR 
(CDC13) cS 7.63 (d , 1 H , J = 6 Hz), 7.30 (dd, 1 H , J = 16, 2.2 
Hz) , 7.07 (m, 1 H , J = 16, 11 , 7.7 Hz), 6.39 (d, 1 H . J = 6 
HzO, 5.81 (d, 1 H , J = 11 Hz) , 5.76 (d, 1 H , J = 7.7 Hz), 4.03 
(d , 1 H , J = 12 Hz), 3.86 (d, 1 H , J = 12Hz), 3.81 (d, IH, J = 
2.2 Hz), 2.09 (br s, IH, exchangeable); HREIMS mlz 206.0550, 
CI1Hl004 req 206.0576. 
Voeltzkowinol C. [aldehyde, (112)] IR (CHC13) 3600-
3200, 1720, 1680 cm- l ; UV (MeOH) 235.6 (£ 6000); UV (CHC13) 
270.6nm (£ 4000); [aldehyde, (112)1 IH NMR (CDC13) 09.46 (s, 
.8H), 7.56 (d, .8H, J = 6 Hz), 6.36 (d, .8H, J = 6 Hz), 7.20 
(d, .8H, J = 11 Hz), 6.72 (m, .8H, J = 17, 11, 9.5 Hz), 5.87 
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(d, . BH , J = 17 Hz, 5.76 (d , .BH, J = 9.5 Hz), 3.7B (d , . BH, 
J = 12 Hz, 3.63 (d , . BH , J = 12 Hz), 3.59 ( s , .BH). [6 -
1 actol , ( 113 ) ] 67.41 (d, . 2H, J = 5 Hz), 6.36 (d , . 2H, J = 
Hz) , 5.4B (d , . 2 H , J = 16 Hz) , 5.36 ( d , . 2 H , J = 9.5 Hz) , 
5.41 ( s , . 2 H) , 3.56 (d , . 2H, J = 11 Hz) , 3.49 (d , 1 H , J = 
Hz), 3.51 (s, .2H); HREIMS mlz 20B.0719, CIIH1204 requires 
20B.0744. 
Recording tD NMR spectra. The NOESY spectrum was 
recorded using a 12BW x lK data matrix. Sixty scans were 
acquired for each experiment. The mixing delay was set at 
the average Tl for the protons of interest (1.75 s) as 
determined by a standard inversion recovery experiment. 
Total measuring time was approximately 16 hours. The fl 
dimension was zero-filled to 512W to satisfy the equation 
HZI/Ptl = HZ2/Pt2 = 1. The spectrum was obtained by 
applying a sinebell filtering function in each dimension 
followed by a symmetrization function. 
For experimental details on the COSY experiment the 
reader is directed to the experimental section for 
Lissoclinum patella. 
The Chemistry of Lissoclinum Patella 
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Extraction and chromatography. Recombined 
chromatography fractions containing "minor components" from 
two previous workups of l. patella (7.0 grams total extract) 
were chromatographed on RP HPLC (Whatman 00S-2; BO:20, 
MeOH:H20) to give prelissoclinamide-2 (~, 33 mg, 0.5% of 
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extract), prepatellamide-B-formate (Ql, 13 mg, 0.2% of 
extract) and a complex mixture of at least five additional 
peptides (53 mg). HPLC of this mixture (Whatman 
partisil-l0; 96:4, CHC13:MeOH) gave preulicyclamide (~, 15 
mg, 0.2% of extract). 
Prelissoclinamide-2 (62). [a]o +18.1° (~2.24, CHC13); 
IR (CHC13) 3387, 3316, 2917, 1680, 1660, 1530 cm- 1; HRFABMS 
m/z 698.2828, C33H44N706S2 (MH+) requires 698.2793. 
Prepatellamide-B-Formate (63). [a]o +36.5° (~ 0.3, 
CHC13); IR 3356, 3316, 2911, 1747, 1661, 1538 cm- 1; HRFABMS 
m/z 823.3254, C39H51N808S2 (MH+) requires 823.3217. 
Preulicyclamide (64). [a]o +5.4° (~0.24, CHC13); IR 
(CHC13) 3369, 3345, 2919, 1660, 1623, 1530 cm- 1; HRFABMS m/z 
696.2652, C33H42N706S2 (MH+) requires 696.2622. 
The Conversion of Lissoclinamide 2 (60) to 
Prelissoclinamide-2 (62). Lissoclinamide 2 (3.5 mg) was 
refluxed in 5% H2S04/MeOH for 1 hour. The reaction mixture 
was then added to a solution of 10% NaOH and allowed to stir 
overnight. The mixture was partitioned with CHC13 (3 X 50 
ml). The CHC13 fraction was dried over anhydrous Na2S04 and 
the solvent removed in vacuo. HPLC purification of the 
mixture (Whatman RP-18, 60:40, MeOH/H20) yielded 
Prelissoclinamide-2 [1 mg, [a]o +22.5° (~0.027, CHC13)]' 
Recording 20-NMR Spectra The COSY 45 pulse sequence is 
90 - T- 45. COSY 45 spectra were recorded using a 32W X lK 
data matrix, and 16 scans were acquired for each tl 
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duration. Total measuring time for a COSY spectrum was 
approximately 30 minutes. The fl dimension was zero-filled 
to 512W to satisfy the equation: HZl/Ptl = HZ2/Pt2 = 1. 
Each spectrum was obtained by applying a sine bell filtering 
function in each dimension followed by a symmetrization 
function. The HETCOR spectra were recorded using a 64W X 
1K data matrix and 600 scans were acquired for each tl 
duration. Total measuring time was approximately 6 hours. 
Each spectrum was obtained by applying a sine bell function 
in each dimension. 
APPENDIX 
NMR DATA FOR THE LISSOCLINUM PEPTIDES 
Table 3. IH NMR Chemical Shift Assignments for the Lissoclinum Peptides 
Assignments are Based on Detailed Analysis of COSY 45 Data 
H at C , Pate11amide A (~) Patellam1de B (66) 
2 4.30 (dd, J = 8. 4 Hz) 4.38 (d. J = 4 Hz) 
3 4.80 (m) - 5.01 
4 
5 4.56 (dd, J = 10, 8 Hz) 1.41 (d, J = 1 Hz) 
6 1.96 (m) -- 5.01 - -
1 1. 58 (m) 1.61 
8 0.13 (t, J = 1 Hz) 2.08 (rn) 
9 0.81 (d, I = 1 Hz) 1.07 (d, J = 6 Hz) 
10 1.05 (d, I = 1 Hz) 
11 
12 7.83 (s) 
13 7.49 (s) 
14 5.22 (m) 
15 2.32 (m) 5.50 (ddd, J = 10, 10, 1 Hz) 
16 1.13 (d, ~ = 1 Hz) 3.45 (dd, J--= 14, 10 Hz) 
3.31 (dd, I ::: 14, 1 Hz) 
11 1.08 (d, ~ = 1 Hz) 
18 7.30 (m, 5H) 
19 4.30 (d. ::: 4 Hz) 
20 4.89 (dg. ::: 6. 4 Hz) 
21 
22 1.47 (d, ::: 6 Hz) 4.29 (d, J ::: 4 Hz) 
23 4.65 (dd. ::: 8. 6 Hz) 5.01 . . --
24 1.96 (m) 
25 1.58 (m) 1.45 (d, J = 7 Hz) 
26 0.15 (t, J = 7 Hz) 4.71 (dd,--J ::: 11, 1 Hz) 
27 0.81 (d, I = 7 Hz) 2.24 (m) -
28 1.61 (m) 
29 0.93 (t, J = 6 Hz) 
30 1.83 (s) 1.09 (d, 1 = 7 Hz) 
31 
32 5.22 (m) 
33 2.32 (m) 7.39 (s) 
34 1.13 (d. J ::: 1 Hz) 
35 1.08 (d, :I ::: 7 Hz) 5.39 (dq, J ::: 9, 7 Hz) 
36 1.14 (d, £= 7 Hz) 
37 
N-1 7.95 (m) 7.62 (d, J = 9 Hz) 
N-2 7.41 (d. J = 10 Hz) 7.62 (m) --
N-3 7.95 (m)- 7.62 (d, J ::: 10 Hz) 















































Table 3. Continued 
Ulicy1amide (54) 
4.26 (d, J = 4 Hz) 
4.82 (dQ,-~ = 1, 4 Hz) 
1.44 (d, J = 1 Hz) 
4.52 (t, ~ = 8 Hz) 
1.9 (m) -
1.35 (m) 
3.25 (m, 3H) 
4.89 (m) 
3.25 (m, 3 Hz) 
2.93 (dd, .!!. = 14, 10 Hz) 
1.30 (s, 5H) 
8.03 (s) 
5.38 (dQ, J = 1, 5 Hz) 
1.11 (d, ~-= 1 Hz) 
8.08 (s) 




0.85 (t, J = 7 Hz) 
0.13 (d, I = 1 Hz) 
1.85 (d, J = 10 Hz) 
8.61 (d, ~ = 1 Hz) 
9.06 (d, I = 5 Hz) 
U1ithiacyc1amide (55) 
4.05 (dd, J = 8, 2 Hz) 
4.11 (dg, ~ = 8, 1 Hz) 
1.1 (d, J = 1 Hz) 
5.24 (ddCfd, J = 9, 6, 4, 2 Hz) 
3.22 (dd, J ~ 14, 6 Hz) 





0.78 (d, J = 1 Hz) 
0.90 (d, I = 1 Hz) 
7.10 (d, J = 9 Hz) 












































Table 3. Continued 
Lissoc1inamide 1 (.§2.) 
4.30 (d, J = 4 Hz) 
4.87 (dq,-.!!. = 6, 4 Hz) 
1.46 (d, J = 6 Hz) 






3.28 (dd, J = 13, 5 Hz) 
2.91 (dd, ~ = 13, 10 Hz) 
7.31 (m, 5H) 
8.05 (s)a 
5.35 (dd, J = 9, 6 Hz) 
2.22 (m) -
1.70 (m) 
0.92 (t, J = 7 Hz) 
1.04 ed, I = 7 Hz) 
8.03 (s)a 
5.15 (t, J = 10 Hz) 
2.78 (dqQ; J = 10, 7, 7 Hz) 
1.08 ed, J ~ 7 Hz) 
0.75 (d, ~ =.7 Hz) 
7.97 (d, J = 10 Hz) 
8.73 (d, ~ = 6 Hz) 
8.97 (d, :I = 6 Hz) 
Li 55011 nami de 2 (!Q) 
4.27 (d, J = 5 Hz) 
4.81 (dq,~ = 6, 5 Hz) 
1.51 (d, J = 6 Hz) 








3.17 (dd, J = 14, 6 Hz) 
3.02 (dd, ~ = 14, 6 Hz) 
7.18 (m, 5H) 
7.99 (s) 
5.33 (dq, J = 8, 7 Hz) 
1.56 (d, .!I.-= 7 Hz) 
5.21 (dd, J = 9.2, 4.6 Hz) 
3.48 (dd, J = 13, 4.6 Hz) 





0.93 (t, J = 8 Hz) 
1.02 (d, I = 7 Hz) 
7.56 (d, J = 10 Hz) 
7.98 (d, J = 6 Hz) 
6.70 (d, I = 8 Hz) 
li 5 soc 1 i nami de 3 (~.!) 
4.23 (d, J .. 5 Hz) 
4.77 (dq,-.!!. 6, 5 Hz) 
1.46 (d, J .. 6 Hz) 






4.95 (ddd, J .. 9, 8, 5 Hz) 
3.21 (dd, S-= 13, 5 Hz) 
2.95 (dd. I = 13, 9 Hz) 
7.30 (m 5H) 
8.07 (s) 
5.37 (dq. J = 7, 7 Hz) 
1.56 (d, .!!.-.. 7 Hz) 
5.21 (dd, J .. 6, 5.2 Hz) 
3.73 (dd. J = 13.8. 5.2 Hz) 





0.91 (t, J .. 7 Hz) 
0.95 (d. I .. 7 Hz) 
7.70 (d. J .. 10 Hz) 
8.58 (d. J .. 8 Hz) 
8.24 (d, I = 7 Hz) 
.,J:::Io 
o 
Table 3. Continued 
H at el Prepatellamide- Preu1icyc1amide (64) 
B-Formate (63) 
2 4.27 (d, J :: 2.6 Hz) 4.43 (d, J = 8.7 Hz) 4.03 (dd, J :: 7.4. 6.6 Hz) 
3 4.95 (dq,--J = 5.3, 2.6 Hz) 4.84 (q. J = 6.5 Hz) 4.70 (dq. I = 7.4, 6.6 Hz) 
4 1. 41 (q, .:f" = 5.3 Hz) 1.29 (d, i :: 6.5 Hz) 1.19 (d, i = 6.6 Hz) 
5 
6 4.63 (m) 4.30 (t, J = 8 Hz) 4.17 (dd, J = B, 7 Hz) 
7 1.97 (m) 1.64 (m) -- 1.80 (m) --
1.30 (m) 2.39 (m) 2.17 (m) 
8 1.50 (m) 1.84 (m) 3.31 (m) 
9 1.03 (d, i = 6 Hz) 3.59 (m) 
2.58 (m) 
10 0.95 (d, i :: 6 Hz) 
11 5.18 (ddd, J :: 9,7,7 Hz) 4.96 (ddd. J = 9.5, 8, 5 Hz) 
12 3.15 (dd, ~= 14, 7 Hz) 3.18 (dd, S-= 13. 5 Hz) 
7.46 (s) 
3.09 (dd, i = 14, 7 Hz) 2.98 (dd, i :: 13, 9.5 Hz) 
13 
14 
15 5.51 (ddd, J :: 10, 10, 6 Hz) 7.36 (m, 5H) 7.35 (m, 5H) 
16 3.29 (dd, S-= 14, 6 Hz) 
3.47 (dd, :I = 14, 10 Hz) 
17 
18 
19 7.33 (m, 5H) 7.95 (s) 7.89 (5) 
20 
21 5.28 (dq, J = 10, 7 Hz) 5.31 (dq, J = 6.6, 5 Hz) 
22 4.76 (d, J = 9 Hz) 1.58 (d, F= 7 Hz) 1.64 (d, F= 6.6 Hz) 
23 5.76 (q, J = 6.6 Hz) 
24 1.43 (d, ~:: 6.6 Hz) 5.25 (m) 
25 8.48 (s) - 3.59 (m) 8.06 (s) 
26 
27 4.65 (m) 5.33 (dd, J = 8.5, 8 Hz) 5.18 (dd, i = 10, 9 Hz) 
28 2.32 (m) 2.58 (m) - 2.70 .. 
29 1.30 (m) 1.40 (m) 1.80 
30 0.86 (t, J :: 7 Hz) 0.97 (t, J = 7.3 Hz) 0.86 (t, J = 7 Hz) 
31 1.03 (d, :I • 6 Hz) 1 • 1 2 (d , i = 7 Hz) 0.71 (d, i :: 6.6 Hz) 
32 
33 
34 7.42 (s) 
35 
36 5.35 (dq, J • 8.5, 7.3 Hz) 
37 1.65 (d, J-. 7.3 Hz) 
N-1 6.78 (d, ~ • 8.5 Hz) 6.89 (d, J = 8 Hz) 8.28 (d, J = 9 Hz) 
N-2 7.95 ( d,--J = 8 Hz) 6.45 (d, J = 8.7 Hz) 6.99 (d. J = 6.6 Hz) 
N-3 7.86 (d, ~= 10 Hz) 8.32 (d, J = 9 Hz) 8.68 (d, J = 8 Hz) +:. 
N-4 7.04 (d, J'" 9 Hz) 8.18 (d, i"" 10 Hz) 9.17 (d, i = 5 Hz) --' N ..5 8.47 (d, l' • 5 Hz) 
Table 4. 13C NMR Assignments for the Lissoclinam Peptides 
Chemical Shift Assignments for Protonated Carbons are Based on Heteronuclear COSY Data 
Carbon No. Patellamide A (ll) Patellamide B (~) lissoc1inamide 1 (59) lissoclinamide 2 (60) lissoclinamide 3 (!!.) 
1 169.5a 173.3a 171.48 182.6a 174.6a 
2 67.4 73.8 75.0 75.6 74.9 
3 72.2 82.5 82.6 80.8 81.7 
4 169.18 168.2a 167.6a 169.1 a 169.0a 
5 52.1 23.2 21.7 21. 7c 21.6 
6 33.3 47.8 56.5 56.7 56.3 
1 24.1 39.0 28.7d 28.7 29.3 8 10.6 25.1 24.7 25.5 28.4 
9 14.9 21.0 47.0 47.3 46.8 
10 171.58 21.0 170.9a 171.8a 170.7a 
11 149.4b 173.0a 53.9 52.0b 52.8 
12 123.0c 147.6b 40.5 37.8 40.3 
13 160.5d 123.6c 136.0 135.6 135.5 
14 54.9 161. ad 128.6 (2C) 128.2 (2C) 128.2 (2C) 
15 31.1 53.3 129.7 (2C) 129.6 (2C) 129.6 (2C) 
16 19.2 40.7 127.2 126.7 126.9 
17 19.2 136.1 169.8a 171.8a 170.6a 
18 111.5a 128.7 (2C) 150.5c 148.3 148.0 
19 73.6 129.2 (2C) 122.9 123.7 123.3 
20 81.6 127.1 160.8b 159.6 159.1 
21 168.5a 172.8a 56.8 47.0 47.3 
22 21.1 13.8 40.8 22.0c 24.4 
23 52.4 82.1 25.0d 171.1a 170.6a 
24 33.3 168.0a 11.9 78.7 78.7 
25 24.9 21.8 15.2 36.2 35.2 
26 11.1 52.5 168.5a 169.1a 169.9a 
27 15.0 32.9 148.1c 54.2b 53.2 
28 . 111.8a 25.1 122.9 38.5 38.9 
29 149.4b 8.8 159.9b 26.6 24.9 
30 123.0c 15.0 55.5 11.7 10.2 
31 160.5d 170.0a 33.0 14.0 14.8 
32 54.9 147.2b 20.2 
33 36.8 123.6c 20.0 
34 11.9 161.6d 





Table 4. Continued 
Carbon' Ulicyc1amide (2.!) Ulithiacyc1amide (.ll) Prepatellamide-B-Formate (21.) 
1 111.9b 170.0a 173.6a 
2 76.3 74.1 74.0 
3 83.3 81.7 81.9 
4 167.7 167.3 168.6 
5 22.9 22.1b 21.0 6 57.5 48.4 51.6 
7 29.8 46.5 39.9 
8 25.ge 170.5a 25.0 
9 54.4~ 160.1 22.2 
10 171.9 124.1 22.5 
11 54.4a 149.2b 172.2~ 12 41.8 48.5 149.2 
13 136.8 46.5 122.8~ 
14 129.5 (2C) 25.3 162.3 
15 130.6 (2C) 22.7c 52.5 
16 128.2b 22.8
c 40.8 
17 171.9 136.3 
18 161.1c 128.8 (2C) 
19 124.3d 129.4 (2C) 
20 151.4c 127.2 
21 49.6 171.7a 
22 25.4b 56.9 23 170.5 69.5 
24 160.5~ 18.9 
25 123.8 161.4 
26 148.ge 171.1a 
27 48.1 54.3 
28 39.0 33.2 
29 26.0e 25.3 
30 10.9 9.9 







• interchangeable signals 
b interchangeable signals 
c interchangeable signals d interchangeable signals 































































e interchangeable signals ~ 
+:=0 
W 
Tab 1 e 5. COSy 45 Connect; v; ti es for the a. -Ami no Protons 
in Lissoclinum Peptides 
COMPOUND CONNECTIONS 
Ulicyclamide (~) H2 H6 
H2 H27 
H6 Hll 
Ulithiacylcamide (.§.§.) * H2 H6 
H2 HI2 




Patel1amide-B (~) H2 H6 
H2 H35 
H22 H26 
Lissoclinamide-I (~) H2 H6 
H2 H30 
Lissoclinamide-2 (60) H2 H6 
H2 H27 
Lis soc 1 i nami de-3 (§.!) H2 H6 
H2 H27 
Prel issoclinamide-2 (g) H2 H6 
H2 H27 
H6 Hll 
Prepatellamide-B-Formate (~~) H2 H36 
H22 HI5 
H22 H27 
Preulicyclamide (.§!) H2 H6 
H2 H27 
* Coupling observable in 10 Spectrum. 
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